Nuvve Holding (NVVE) 10-Q/A31 Mar 232022 Q2 Quarterly report (amended)Financial data

Company Profile

Cover

Cover - shares	6 Months Ended
Cover - shares	Jun. 30, 2022	Aug. 04, 2022
Document Information [Line Items]
Document Type	10-Q/A
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	001-40296
Entity Registrant Name	NUVVE HOLDING CORP.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	86-1617000
Entity Address, Address Line One	2468 Historic Decatur Road,
Entity Address, City or Town	San Diego,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	92106
City Area Code	(619)
Local Phone Number	456-5161
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		22,363,540
Amendment Flag	false
Entity Central Index Key	0001836875
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	NVVE
Security Exchange Name	NASDAQ
Warrants
Document Information [Line Items]
Title of 12(b) Security	Warrants to Purchase Common Stock
Trading Symbol	NVVEW
Security Exchange Name	NASDAQ

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)		Jun. 30, 2022	Dec. 31, 2021
Current assets
Cash	[1]	$ 14,890,242	$ 32,360,520
Restricted cash	[1]	480,000	380,000
Accounts receivable	[1]	1,958,656	1,886,708
Inventories	[1]	10,796,032	11,118,188
Prepaid expenses and other current assets	[1]	2,384,575	1,036,645
Total Current Assets	[1]	30,509,505	46,782,061
Property and equipment, net	[1]	600,546	356,194
Intangible assets, net	[1]	1,411,358	1,481,077
Investments	[1]	1,670,951	670,951
Right-of-use operating assets	[1]	5,195,474	3,483,042
Financing receivables	[1]	238,624	138,161
Security deposit, long-term	[1]	3,057	3,057
Total Assets	[1]	39,629,515	52,914,543
Current Liabilities
Accounts payable	[1]	3,327,366	5,738,873
Accrued expenses	[1]	2,392,820	2,874,018
Deferred revenue	[1]	781,922	719,771
Operating lease liabilities - current	[1]	455,064	41,513
Other liabilities	[1]	111,387	110,574
Total Current Liabilities	[1]	7,068,559	9,484,749
Operating lease liabilities - noncurrent	[1]	5,053,219	3,441,642
Warrants liability	[1]	182,000	9,543,000
Derivative liability - non-controlling redeemable preferred shares	[1]	491,012	511,948
Other long-term liabilities	[1]	15,120	18,860
Total Liabilities	[1]	12,809,910	23,000,199
Commitments and Contingencies	[1]
Mezzanine equity
Redeemable non-controlling interests, preferred shares, zero par value, 1,000,000 shares authorized, 3,138 shares issued and outstanding at June 30, 2022 and December 31, 2021; aggregate liquidation preference of $3,330,071 at June 30, 2022	[1]	3,224,832	2,901,899
Stockholders’ (Deficit) Equity
Common stock, $0.0001 par value, 100,000,000 shares authorized; 19,709,763 and 18,861,130 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	[1]	1,986	1,888
Additional paid-in capital	[1]	129,459,590	122,336,607
Accumulated other comprehensive income (loss)	[1]	73,448	113,446
Accumulated deficit	[1]	(102,836,347)	(92,937,863)
Nuvve Stockholders’ Equity (Deficit)	[1]	26,698,677	29,514,078
Non-controlling interests	[1]	(3,244,754)	(2,501,633)
Total Stockholders’ Equity (Deficit)	[1],[2]	23,453,923	27,012,445
Total Liabilities, Mezzanine equity and Stockholders’ Equity	[1]	$ 39,629,515	$ 52,914,543
Temporary equity, par value (in Dollars per share)		$ 0	$ 0
Temporary equity, shares authorized (in Shares)		1,000,000	1,000,000
Class D Incentive Units
Mezzanine equity
Class D Incentive units, zero par value, 1,000,000 units authorized, 250,000 units issued and outstanding at June 30, 2022	[1]	$ 140,850	$ 0
Stockholders’ (Deficit) Equity
Temporary equity, par value (in Dollars per share)		$ 0
Temporary equity, shares authorized (in Shares)		1,000,000
Cumulative Preferred Stock
Stockholders’ (Deficit) Equity
Preferred stock, $0.0001 par value, 1,000,000 shares authorized; zero shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	[1]	$ 0	$ 0

[1]Note 2.[2]See Note 2.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($)	Jun. 30, 2022	Dec. 31, 2021
Temporary equity, par value (in Dollars per share)	$ 0	$ 0
Temporary equity, shares authorized (in Shares)	1,000,000	1,000,000
Temporary equity, shares issued (in Shares)	3,138	3,138
Temporary equity, shares outstanding (in Shares)	3,138	3,138
Temporary equity, liquidation preference	$ 3,330,071
Preferred stock par value (in Dollars per share)	$ 0.0001
Preferred stock, shares authorized (in Shares)	1,000,000
Common stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in Shares)	100,000,000	100,000,000
Common stock, shares issued (in Shares)	19,709,763	18,861,130
Common stock, shares outstanding (in Shares)	19,709,763	18,861,130
Class D Incentive Units
Temporary equity, par value (in Dollars per share)	$ 0
Temporary equity, shares authorized (in Shares)	1,000,000
Temporary equity, shares issued (in Shares)	250,000
Temporary equity, shares outstanding (in Shares)	250,000
Cumulative Preferred Stock
Preferred stock par value (in Dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in Shares)	1,000,000	1,000,000
Preferred stock, shares issued (in Shares)	0	0
Preferred stock, shares outstanding (in Shares)	0	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended				6 Months Ended
		Jun. 30, 2022		Jun. 30, 2021		Jun. 30, 2022		Jun. 30, 2021
Revenue
Total revenue	[1]	$ 1,301,727		$ 981,330		$ 3,672,760		$ 1,780,362
Operating expenses
Cost of product and service revenue	[1]	1,034,596		362,658		3,176,908		489,886
Selling, general, and administrative	[1]	8,136,522		5,269,791		15,762,072		9,752,531
Research and development	[1]	2,170,139		1,689,245		4,305,714		2,952,195
Total operating expenses	[1]	11,341,257		7,321,694		23,244,694		13,194,612
Operating loss	[1]	(10,039,530)		(6,340,364)		(19,571,934)		(11,414,250)
Other income (expense)
Interest income (expense)	[1]	6,945		1,984		8,403		(595,565)
Financing costs	[1]	0		(43,818,000)		0		(43,818,000)
Change in fair value of warrants liability	[1]	4,585,000		(3,497,230)		9,361,000		(3,075,400)
Change in fair value of derivative liability	[1]	(32,536)		0		20,936		0
Other, net	[1]	22,020		503,676		(7,767)		391,561
Total other (expense) income, net	[1]	4,581,429		(46,809,570)		9,382,572		(47,097,404)
Loss before taxes	[1]	(5,458,101)		(53,149,934)		(10,189,362)		(58,511,654)
Income tax (benefit) expense	[1]	0		1,000		0		1,000
Net loss		(5,458,101)	[1],[2]	(53,150,934)	[1]	(10,189,362)	[1]	(58,512,654)	[3]
Less: Net loss attributable to non-controlling interests	[1]	(189,945)		0		(290,878)		0
Net loss attributable to Nuvve Holding Corp.	[1]	(5,268,156)		(53,150,934)		(9,898,484)		(58,512,654)
Less: Preferred dividends on redeemable non-controlling interests	[1]	65,296		0		129,311		0
Less: Accretion on redeemable non-controlling interests preferred shares	[1]	161,466		0		322,932		0
Net loss attributable to Nuvve common stockholders	[1]	$ (5,494,918)		$ (53,150,934)		$ (10,350,727)		$ (58,512,654)
Net loss per share attributable to Nuvve common stockholders, basic (in Dollars per share)	[1]	$ (0.29)		$ (2.85)		$ (0.55)		$ (4.02)
Net loss per share attributable to Nuvve common stockholders, diluted (in Dollars per share)	[1]	$ (0.29)		$ (2.85)		$ (0.55)		$ (4.02)
Weighted-average shares used in computing net loss per share attributable to Nuvve common stockholders, basic (in Shares)	[1]	19,064,854		18,668,009		18,965,167		14,560,862
Weighted-average shares used in computing net loss per share attributable to Nuvve common stockholders, diluted (in Shares)	[1]	19,064,854		18,668,009		18,965,167		14,560,862
Products and services
Revenue
Total revenue	[1]	$ 1,068,029		$ 766,516		$ 3,321,813		$ 1,078,419
Grants
Revenue
Total revenue	[1]	$ 233,698		$ 214,814		$ 350,947		$ 701,943

[1]Note 2.[2]See Note 2.[3]Note 2.

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)		3 Months Ended				6 Months Ended
		Jun. 30, 2022		Jun. 30, 2021		Jun. 30, 2022		Jun. 30, 2021
Statement of Comprehensive Income [Abstract]
Net loss		$ (5,458,101)	[1],[2]	$ (53,150,934)	[1]	$ (10,189,362)	[1]	$ (58,512,654)	[3]
Other comprehensive (loss) income, net of taxes
Foreign currency translation adjustments, net of taxes	[3]	(26,314)	[2]	(20,146)		(39,998)		96,603
Total Comprehensive loss	[3]	(5,484,415)		(53,171,080)		(10,229,360)		(58,416,051)
Less: Comprehensive loss attributable to non-controlling interests	[3]	(189,945)		0		(290,878)		0
Comprehensive loss attributable to Nuvve Holding Corp.	[3]	(5,294,470)		(53,171,080)		(9,938,482)		(58,416,051)
Less: Preferred dividends on redeemable non-controlling interests	[3]	(65,296)		0		(129,311)		0
Less: Accretion on redeemable non-controlling interests preferred shares	[3]	(161,466)		0		(322,932)		0
Comprehensive loss attributable to Nuvve common stockholders	[3]	$ (5,067,708)		$ (53,171,080)		$ (9,486,239)		$ (58,416,051)

[1]Note 2.[2]See Note 2.[3]Note 2.

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)		Total		Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit	Non-controlling Interests	Series A Convertible Preferred Stock Preferred Stock
Balances (in Shares) at Dec. 31, 2020				26,162,122					16,789,088
Balances at Dec. 31, 2020		$ (880,710)		$ 2,616	$ 19,650,659	$ (77,841)	$ (20,457,823)		$ 1,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of shares due to merger capitalization (in Shares)				(17,039,126)					(16,789,088)
Conversion of shares due to merger capitalization		0		$ (1,704)	3,383				$ (1,679)
Balances, as previously reported and effect of reverse recapitalization (in Shares)				9,122,996
Balances as previously reported and effect of reverse recapitalization		(880,710)		$ 912	19,654,042	(77,841)	(20,457,823)
Beneficial conversion feature - convertible debenture		427,796			427,796
Conversion of convertible debenture (in Shares)				544,178
Conversion of convertible debenture		3,999,435		$ 54	3,999,381
Repurchase of shares (in Shares)				(600,000)
Repurchase of common stock from EDF		(6,000,000)		$ (60)	(5,999,940)
Assumption of private warrant liability from Newborn		(1,253,228)			(1,253,228)
Merger recapitalization, net of share redemption of issuance costs (in Shares)				8,060,418
Merger recapitalization, net of share redemption of $18,629 and issuance costs of $5,979,675		51,751,363		$ 806	51,750,557
Issuance of common shares (in Shares)				208,532
Issuance of common shares		2,085,320		$ 21	2,085,299
PIPE offering, less issuance costs (in Shares)				1,425,000
PIPE offering, less issuance costs of $2,500		14,247,500		$ 143	14,247,357
Proceeds from forward option put exercise		(2,000,000)			(2,000,000)
Stock-based compensation		262,105			262,105
Currency translation adjustment		116,749				116,749
Net loss		(5,361,720)					(5,361,720)
Balances (in Shares) at Mar. 31, 2021				18,761,124					0
Balance at Mar. 31, 2021		57,394,610		$ 1,876	83,173,369	38,908	(25,819,543)		$ 0
Balances (in Shares) at Dec. 31, 2020				26,162,122					16,789,088
Balances at Dec. 31, 2020		(880,710)		$ 2,616	19,650,659	(77,841)	(20,457,823)		$ 1,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Currency translation adjustment	[1]	96,603
Net loss	[1]	(58,512,654)
Balances (in Shares) at Jun. 30, 2021				18,626,624					0
Balance at Jun. 30, 2021		39,889,025		$ 1,863	118,838,877	18,762	(78,970,477)		$ 0
Balances (in Shares) at Dec. 31, 2020				26,162,122					16,789,088
Balances at Dec. 31, 2020		(880,710)		$ 2,616	19,650,659	(77,841)	(20,457,823)		$ 1,679
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		27,200,000
Balances (in Shares) at Dec. 31, 2021	[2]			18,861,130
Balance at Dec. 31, 2021	[2]	27,012,445	[3]	$ 1,888	122,336,607	113,446	(92,937,863)	$ (2,501,633)
Balances (in Shares) at Mar. 31, 2021				18,761,124					0
Balances at Mar. 31, 2021		57,394,610		$ 1,876	83,173,369	38,908	(25,819,543)		$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of shares (in Shares)				(134,500)
Repurchase of common stock from EDF		0		$ (13)	13
Issuance of common shares (in Shares)				0
Issuance of common shares		0
Stock-based compensation		1,090,603			1,090,603
Additional merger recapitalization costs		(265,736)			(265,736)
Issuance of warrants to Stonepeak and Evolve (As Restated)		22,256,628			22,256,628
Issuance of options to purchase shares of common stock to Stonepeak and Evolve		12,584,000			12,584,000
Currency translation adjustment		(20,146)	[1]			(20,146)
Net loss		(53,150,934)	[4]				(53,150,934)
Balances (in Shares) at Jun. 30, 2021				18,626,624					0
Balance at Jun. 30, 2021		39,889,025		$ 1,863	118,838,877	18,762	(78,970,477)		$ 0
Balances (in Shares) at Dec. 31, 2021	[2]			18,861,130
Balances at Dec. 31, 2021	[2]	27,012,445	[3]	$ 1,888	122,336,607	113,446	(92,937,863)	(2,501,633)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and vesting of restricted stock (in shares)	[2]			30,370
Exercise of stock options and vesting of restricted stock	[2]	3		$ 3
Stock-based compensation	[2]	1,455,641			1,455,641
Currency translation adjustment	[2]	(13,684)				(13,684)
Preferred dividends - non-controlling interest	[2]	(64,015)						(64,015)
Accretion on redeemable non-controlling interests preferred shares	[2]	(161,466)						(161,466)
Net loss	[2]	(4,731,261)					(4,630,328)	(100,933)
Balances (in Shares) at Mar. 31, 2022	[2]			18,891,500
Balance at Mar. 31, 2022	[2]	23,497,663		$ 1,891	123,792,248	99,762	(97,568,191)	(2,828,047)
Balances (in Shares) at Dec. 31, 2021	[2]			18,861,130
Balances at Dec. 31, 2021	[2]	27,012,445	[3]	$ 1,888	122,336,607	113,446	(92,937,863)	(2,501,633)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Currency translation adjustment	[1]	(39,998)
Net loss	[4]	(10,189,362)
Balances (in Shares) at Jun. 30, 2022	[2]			19,709,763
Balance at Jun. 30, 2022	[2]	23,453,923	[3]	$ 1,986	129,459,590	73,448	(102,836,347)	(3,244,754)
Balances (in Shares) at Mar. 31, 2022	[2]			18,891,500
Balances at Mar. 31, 2022	[2]	23,497,663		$ 1,891	123,792,248	99,762	(97,568,191)	(2,828,047)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and vesting of restricted stock (in shares)	[2]			360,018
Exercise of stock options and vesting of restricted stock	[2]	173,625		$ 50	173,575
Issuance of common shares (in Shares)	[2]			323,746
Issuance of common shares	[2]	1,859,685		$ 32	1,859,653
Proceeds from forward option put exercise (in Shares)	[2]			134,499
Proceeds from forward option put exercise	[2]	1,994,072		$ 13	1,994,059
Stock-based compensation	[2]	1,640,055			1,640,055
Currency translation adjustment	[2]	(26,314)	[1]			(26,314)
Preferred dividends - non-controlling interest	[2]	(65,296)
Accretion on redeemable non-controlling interests preferred shares	[2]	(161,466)
Net loss	[2]	(5,458,101)	[4]				(5,268,156)	(189,945)
Balances (in Shares) at Jun. 30, 2022	[2]			19,709,763
Balance at Jun. 30, 2022	[2]	$ 23,453,923	[3]	$ 1,986	$ 129,459,590	$ 73,448	$ (102,836,347)	$ (3,244,754)

[1]Note 2.[2]See Note 2.[3]Note 2.[4]Note 2.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) (Parenthetical)	3 Months Ended
	Mar. 31, 2021 USD ($)
Statement of Stockholders' Equity [Abstract]
Merger recapitalization, net of share redemption	$ 18,629
Issuance costs	5,979,675
Less issuance costs	$ 2,500

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)		3 Months Ended							6 Months Ended				12 Months Ended
		Jun. 30, 2022		Mar. 31, 2022		Jun. 30, 2021		Mar. 31, 2021	Jun. 30, 2022		Jun. 30, 2021		Dec. 31, 2021	Dec. 31, 2020
Operating activities
Net loss		$ (5,458,101)	[1],[2]	$ (4,731,261)	[2]	$ (53,150,934)	[1]	$ (5,361,720)	$ (10,189,362)	[1]	$ (58,512,654)	[3]	$ 27,200,000	$ 4,700,000
Adjustments to reconcile to net loss to net cash used in operating activities
Depreciation and amortization									137,755		81,874
Share-based compensation									3,357,859		1,352,708
Financing costs									0		43,818,000
Beneficial conversion feature on convertible debenture									0		427,796
Accretion of discount on convertible debenture									0		116,147
Change in fair value of warrants liability	[1]	(4,585,000)				3,497,230			(9,361,000)		3,075,400
Change in fair value of derivative liability									(20,936)		0
Loss on disposal of asset									0		1,381
Gain on extinguishment of PPP Loan									0		(492,100)
Noncash lease expense									283,251		(1,003)
Change in operating assets and liabilities
Accounts receivable									(74,278)		(139,140)
Inventory									322,156		(3,164,653)
Prepaid expenses and other assets									(1,462,221)		(2,209,159)
Accounts payable									(2,409,448)		330,890
Accrued expenses									(684,517)		1,595,165
Deferred revenue									79,576		305,922
Net cash used in operating activities									(20,021,165)		(13,413,426)
Investing activities
Proceeds from sale of property and equipment									0		7,969
Purchase of property and equipment									(317,225)		0
Investments									(1,000,000)		0
Net cash (used) provided in investing activities									(1,317,225)		7,969
Financing activities
Proceeds from Newborn Escrow Account									0		58,184,461
Redemption of Newborn shares									0		(18,629)
Issuance costs related to reverse recapitalization and PIPE offering									0		(3,970,657)
Proceeds from PIPE offering									0		14,250,000
Repayment of Newborn sponsor loans									0		(487,500)
Repurchase of common stock from EDF									0		(6,000,000)
Newborn cash acquired									0		50,206
Purchase of stock from investor									0		(2,000,000)
Payment of financing costs									0		(531,527)
Proceeds from forward option put exercise									1,994,073		0
Proceeds from common stock offering, net of offering costs									1,859,685		0
Payment of finance lease Obligations									(4,425)		(1,989)
Proceeds from exercise of stock options									173,575		0
Net cash (used) provided in financing activities									4,022,908		59,474,365
Effect of exchange rate on cash									(54,796)		98,193
Net increase (decrease) in cash and restricted cash									(17,370,278)		46,167,101
Cash and restricted cash at beginning of year				$ 32,740,520				$ 2,275,895	32,740,520		2,275,895		2,275,895
Cash and restricted cash at end of period		$ 15,370,242				$ 48,442,996			15,370,242		48,442,996		$ 32,740,520	$ 2,275,895
Supplemental Disclosure of Noncash Financing Activity
Conversion of preferred stock to common stock									0		1,679
Conversion of debenture and accrued interest to common shares									0		3,999,435
Conversion of shares due to reverse recapitalization									0		3,383
Issuance of common stock for merger success fee									0		2,085,299
Non-cash merger transaction costs									0		2,085,299
Accrued transaction costs related to reverse recapitalization									0		189,434
Issuance of private warrants									0		1,253,228
Forgiveness of PPP Loan									0		492,100
Issuance of Stonepeak and Evolve warrants									0		27,640,000
Issuance of Stonepeak and Evolve options									0		12,584,000
Transfer of Inventory to property and equipment									$ 87,095		$ 0

[1]Note 2.[2]See Note 2.[3]Note 2.

Organization and Description of

Organization and Description of Business	6 Months Ended
Organization and Description of Business	Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Description of Business Nuvve Holding Corp., a Delaware corporation headquartered in San Diego, California (the “Company” or “Nuvve”), was founded on November 10, 2020 under the laws of the state of Delaware. On March 19, 2021, the Company (at the time known as NB Merger Corp.) acquired the outstanding shares of Nuvve Corporation (“Nuvve Corp.”), and the Company changed its name to Nuvve Holding Corp. Structure of the Company Nuvve has two wholly owned subsidiaries, Nuvve Corp. and Nuvve Co (Nuvve Japan). Nuvve Corp. has three wholly owned subsidiaries: (1) Nuvve Denmark ApS, (“Nuvve Denmark”), a company registered in Denmark, (2) Nuvve SaS, a company registered in France, and (3) Nuvve LTD, a company registered in United Kingdom. In March 2020, following the establishment of its investment in Dreev S.A.S. ('Dreev") in 2019 (Note 6), the Company ceased operations of its subsidiary, Nuvve SaS in France. The two employees of Nuvve SaS resigned from the Company in March 2020 and were concurrently hired by Dreev. Financial results for Nuvve SaS are included in the Company’s financial results through the cessation of operations. On August 4, 2021, the Company formed Levo Mobility LLC, a Delaware limited liability company ("Levo"), with Stonepeak Rocket Holdings LP, a Delaware limited partnership ("Stonepeak"), and Evolve Transition Infrastructure LP, a Delaware limited partnership ("Evolve"). Levo is a consolidated entity of the Company. Please see Note 2 for the principles of consolidation. Levo is a sustainable infrastructure company focused on rapidly advancing the electrification of transportation by funding V2G-enabled EV fleet deployments as of June 30, 2022. Levo utilizes Nuvve’s V2G technology and committed capital from Stonepeak and Evolve to offer Fleet-as-a-Service for school buses, last-mile delivery, ride hailing and ride sharing, municipal services, and more to eliminate the primary barriers to EV fleet adoption including large upfront capital investments and lack of expertise in securing and managing EVs and associated charging infrastructure. Levo's turnkey solution simplifies and streamlines electrification, can lower the total cost of EV operation for fleet owners, and supports the grid when the EVs are not in use. For a fixed monthly payment with no upfront cost, Levo will provide the EVs, such as electric school buses, charging infrastructure powered by Nuvve’s V2G platform, EV and charging station maintenance, energy management, and technical advice. Levo initially focuses on electrifying school buses, providing associated charging infrastructure, and delivering V2G services to enable safer and healthier transportation for children while supporting carbon dioxide emission reduction, renewable energy integration, and improved grid resiliency.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
Summary of Significant Accounting Policies	Jun. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies For a detailed discussion about the Company’s significant accounting policies, see Note 2, “ Summary of Significant Accounting Policies ,” in the Notes to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 (the “2021 Form 10-K”). During the six months ended June 30, 2022, there were no significant updates made to the Company’s significant accounting policies. Basis of Presentation The accompanying unaudited (i) condensed consolidated balance sheet as of December 31, 2021, which has been derived from audited financial statements, and (ii) the unaudited interim condensed financial statements have been prepared in accordance pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. Therefore, it is suggested that these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes in the 2021 Form 10-K, filed with the SEC on March 31, 2022. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss, cash flows, and stockholders’ equity for the interim periods, but are not necessarily indicative of the results to be anticipated for the full year 2022 or any future period. In accordance with Accounting Standards Codification ("ASC") 205-40, Presentation of Financial Statements - Going Concern, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the that the consolidated financial statements are issued. Since inception, the Company has incurred recurring losses and negative cash flows from operations since inception and has an accumulated deficit of $102.8 million as of June 30, 2022. Nuvve incurred operating losses of approximately $19.6 million as of the six months ended June 30, 2022, and $27.2 million and $4.7 million for the years ended December 31, 2021, and 2020, respectively. As of June 30, 2022, Nuvve had a cash balance, working capital, and stockholders’ equity of $14.9 million, $23.4 million and $23.5 million, respectively. The Company continues to expect to generate operating losses and negative cash flows and may need additional funding to support its planned operating activities through profitability. The transition to profitability is dependent upon the successful expanded commercialization of the Company's Grid Integrated Vehicle ("GIVe") platform and the achievement of a level of revenues adequate to support its cost structure. On May 5, 2022, the Company entered into an at-the-market offering agreement in which the Company from time to time during the term of the sales agreement, offer and sell shares of its common stock having an aggregate offering price up to a total of $25.0 million in gross proceeds. Shares of common stock sold under the sales agreement are offered and sold pursuant to the Company's shelf registration statement. During the six months ended June 30, 2022, the Company sold 323,746 shares of common stock pursuant to the sales agreement at an average price of $6.12 per share for aggregate net proceeds of approximately $1.9 million. Additionally, during the month of July 2022, the Company sold 469,136 shares of common stock pursuant to the sales agreement at an average price of $4.17 per share for aggregate net proceeds of approximately $1.9 million. In July 2022, the Company had a direct equity offering of its common stock. See Note 19 for details. The aggregate gross proceeds to the Company from the offering were approximately $14.0 million and net proceeds were $13.1 million . The Company expects its cash and cash equivalents as of August 11, 2022 will be sufficient to fund current planned operations for at least the next twelve months from the date of issuance of these consolidated financial statements. Management's expectations with respect to its ability to fund current planned operations is based on estimates that are subject to risks and uncertainties. Actual results could be different from management's estimates and should actual results be less favorable than these estimates management would ultimately need to take corrective steps to improve future operating results and its financial condition. Restatement of Previously Issued Financial Statements Subsequent to the issuance of the company’s consolidated financial statements as of June 30, 2022 and 2021, errors were identified relating to the following: (1) Unvested warrants issued to Stonepeak and Evolve in May 2021, as described in Note 11, should be accounted for as a single unit of account as opposed to multiple units of account. As a result, these unvested warrants, which were previously recorded in equity, have been reclassified to liabilities on the consolidated balance sheet. As a single unit of account, the unvested warrants’ settlement value is impacted by the amount of capital expenditures associated with Levo’s customer contracts, which caused the unvested warrants to not be indexed to the Company's equity. The unvested warrant liability is adjusted to its estimated fair value at each reporting date. (2) As part of the fair value of warrants and stock option (“Instruments”) granted to Stonepeak and Evolve in May 2021, in conjunction with the formation of Levo, the Company inaccurately capitalized the costs incurred to deferred financing costs, and should have expensed such costs. The Company determined that there was not sufficient basis to record deferred financing costs associated with Stonepeak and Evolve’s plans to contribute capital to the Levo venture. As a result, the estimated fair value of the Instruments that were previously recorded as a capitalized asset are corrected to recognize an expense upon issuance of the Instruments during the second quarter of 2021. The expense is non-cash and does not impact the existing conditional capital commitment the Company has from Stonepeak and Evolve or the pursuit of customer deployments funded by this conditional capital commitment. The associated income tax expense or benefit and related deferred tax assets or liabilities have been reflected, including the impact of valuation allowance. The following tables summarize the effect of the aforementioned adjustments on the Company's Condensed Consolidated Balance Sheets as of June 30, 2022, and the Company's Condensed Consolidated Statements of Operations, and Condensed Consolidated Statements of Cash Flows for the three and six months ended June 30, 2022: Condensed Consolidated Balance Sheet June 30, 2022 June 30, 2022 As Previously Reported Adjustment As Restated Redeemable non-controlling interests, preferred shares, zero par value, 1,000,000 shares authorized, 3,138 shares issued and outstanding at June 30, 2022 and December 31, 2021; aggregate liquidation preference of $3,330,071 at June 30, 2022 $ 3,208,360 $ 16,472 $ 3,224,832 Additional paid-in capital $ 134,261,487 $ (4,801,897) $ 129,459,590 Accumulated deficit $ (107,629,843) $ 4,793,496 $ (102,836,347) Nuvve Stockholders’ Equity (Deficit) $ 26,707,078 $ (8,401) $ 26,698,677 Non-controlling interests $ (3,236,683) $ (8,071) $ (3,244,754) Total Stockholders’ Equity (Deficit) $ 23,470,395 $ (16,472) $ 23,453,923 Three Months Ended June 30, Three Months Ended June 30, Three Months Ended June 30, Three Months Ended June 30, 2022 2022 2021 2021 Condensed Consolidated Statements of Operations As Previously Reported Adjustment As Restated As Previously Reported Adjustment As Restated Financing costs $ (43,562,847) $ 43,562,847 $ — $ — $ (43,818,000) $ (43,818,000) Change in fair value of warrants liability $ 251,000 $ 4,334,000 $ 4,585,000 $ (351,602) $ (3,145,628) $ (3,497,230) Total other (expense) income, net $ (43,315,418) $ 47,896,847 $ 4,581,429 $ 154,058 $ (46,963,628) $ (46,809,570) Loss before taxes $ (53,354,948) $ 47,896,847 $ (5,458,101) $ (6,186,306) $ (46,963,628) $ (53,149,934) Net loss $ (53,354,948) $ 47,896,847 $ (5,458,101) $ (6,187,306) $ (46,963,628) $ (53,150,934) Less: Net loss attributable to non-controlling interests $ (2,110,903) $ 1,920,958 $ (189,945) $ — $ — $ — Net loss attributable to Nuvve Holding Corp. $ (51,244,045) $ 45,975,889 $ (5,268,156) $ (6,187,306) $ (46,963,628) $ (53,150,934) Net loss attributable to Nuvve common stockholders $ (51,470,807) $ 45,975,889 $ (5,494,918) $ (6,187,306) $ (46,963,628) $ (53,150,934) Net loss per share attributable to Nuvve common stockholders, basic and diluted $ (2.70) $ 2.41 $ (0.29) $ (0.33) $ (2.52) $ (2.85) Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, 2022 2022 2021 2021 Condensed Consolidated Statements of Operations As Previously Reported Adjustment As Restated As Previously Reported Adjustment As Restated Financing costs $ (43,562,847) $ 43,562,847 $ — $ — $ (43,818,000) $ (43,818,000) Change in fair value of warrants liability $ 684,000 $ 8,677,000 $ 9,361,000 $ 70,228 $ (3,145,628) $ (3,075,400) Total other (expense) income, net $ (42,857,275) $ 52,239,847 $ 9,382,572 $ (133,776) $ (46,963,628) $ (47,097,404) Loss before taxes $ (62,429,209) $ 52,239,847 $ (10,189,362) $ (11,548,026) $ (46,963,628) $ (58,511,654) Net loss $ (62,429,209) $ 52,239,847 $ (10,189,362) $ (11,549,026) $ (46,963,628) $ (58,512,654) Less: Net loss attributable to non-controlling interests $ (2,211,837) $ 1,920,959 $ (290,878) $ — $ — $ — Net loss attributable to Nuvve Holding Corp. $ (60,217,372) $ 50,318,888 $ (9,898,484) $ (11,549,026) $ (46,963,628) $ (58,512,654) Net loss attributable to Nuvve common stockholders $ (60,669,615) $ 50,318,888 $ (10,350,727) $ (11,549,026) $ (46,963,628) $ (58,512,654) Net loss per share attributable to Nuvve common stockholders, basic and diluted $ (3.20) $ 2.65 $ (0.55) $ (0.79) $ (3.23) $ (4.02) Three Months Ended June 30, Three Months Ended June 30, Three Months Ended June 30, Three Months Ended June 30, 2022 2022 2021 2021 CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS As Previously Reported Adjustment As Restated As Previously Reported Adjustment As Restated Net loss $ (53,354,948) 47,896,847 $ (5,458,101) $ (6,187,306) (46,963,628) $ (53,150,934) Less: Comprehensive loss attributable to non-controlling interests $ (2,110,903) 1,920,958 $ (189,945) $ — — — Comprehensive loss attributable to Nuvve common stockholders $ (51,043,497) 45,975,789 $ (5,067,708) $ (6,207,452) (46,963,628) $ (53,171,080) Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, 2022 2022 2021 2021 CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS As Previously Reported Adjustment As Restated As Previously Reported Adjustment As Restated Net loss $ (62,429,209) 52,239,847 $ (10,189,362) $ (11,549,026) (46,963,628) $ (58,512,654) Less: Comprehensive loss attributable to non-controlling interests $ (2,211,837) 1,920,959 $ (290,878) $ — — $ — Comprehensive loss attributable to Nuvve common stockholders $ (59,805,127) 50,318,888 $ (9,486,239) $ (11,452,423) (46,963,628) $ (58,416,051) CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY As Previously Reported Adjustment As Restated Issuance of warranties to Stonepeak and Evolve $ 30,234,000 $ (7,977,372) $ 22,256,628 Net Loss $ (6,187,306) $ (46,963,628) $ (53,150,934) Balance June 30, 2021 $ 94,830,025 $ (54,941,000) $ 39,889,025 Net Loss $ (9,074,261) $ 4,343,000 $ (4,731,261) Balance March 31, 2022 $ 71,410,982 $ (47,913,319) $ 23,497,663 Net Loss $ (53,354,948) $ 47,896,847 $ (5,458,101) Balance June 30, 2022 $ 23,470,395 $ (16,472) $ 23,453,923 Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, 2022 2022 2021 2021 Condensed Consolidated Statements of Cash Flows As Previously Reported Adjustment As Restated As Previously Reported Adjustment As Restated Operating activities Net loss $ (62,429,209) $ 52,239,847 $ (10,189,362) $ (11,549,026) $ (46,963,628) $ (58,512,654) Adjustments to reconcile to net loss to net cash used in operating activities Financing costs $ 43,562,847 $ (43,562,847) $ — $ — $ 43,818,000 $ 43,818,000 Change in fair value of warrants liability $ (684,000) $ (8,677,000) $ (9,361,000) $ (70,228) $ 3,145,628 $ 3,075,400 Net cash used in operating activities $ (20,021,165) $ — $ (20,021,165) $ (13,413,426) $ — $ (13,413,426) Principles of Consolidation The condensed consolidated financial statements include the accounts and operations of the Company, its wholly owned subsidiaries and its consolidated variable interest entity. All intercompany accounts and transactions have been eliminated upon consolidation. Variable Interest Entities Pursuant to the consolidation guidance, the Company first evaluates whether it holds a variable interest in an entity in which it has a financial relationship and, if so, whether or not that entity is a variable interest entity ("VIE"). A VIE is an entity with insufficient equity at risk for the entity to finance its activities without additional subordinated financial support or in which equity investors lack the characteristics of a controlling financial interest. If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company concludes that it is the primary beneficiary and consolidates the VIE if the Company has both (i) the power to direct the activities of the VIE that most significantly influence the VIE's economic performance, and (ii) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. The Company formed Levo with Stonepeak and Evolve, in which the Company owns 51% of Levo's common units. The Company has determined that Levo is a VIE in which the Company is the primary beneficiary. Accordingly, the Company consolidates Levo and records a non-controlling interest for the share of the entity owned by Stonepeak and Evolve. Assets and Liabilities of Consolidated VIEs The Company's condensed consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders’ interests are reflected in "Net loss attributable to non-controlling interests" in the condensed consolidated statements of operations and "Non-controlling interests" in the condensed consolidated balance sheets. See Note 18 for details of non-controlling interests. The Company began consolidating the assets, liabilities and results of operations of Levo during the quarter ended September 30, 2021. The creditors of the consolidated VIE do not have recourse to the Company other than to the assets of the consolidated VIEs. The following table summarizes the carrying amounts of Levo assets and liabilities included in the Company’s condensed consolidated balance sheets at June 30, 2022: June 30, 2022 Assets Cash $ 28,068 Total Assets $ 28,068 Liabilities and Mezzanine Equity Accrued expenses $ 212,071 Derivative liability - non-controlling redeemable preferred shares 491,012 Total Liabilities $ 703,083 Redeemable Non-Controlling Interest - Mezzanine Equity Redeemable non-controlling interest represents the shares of the preferred stock issued by Levo to Stonepeak and Evolve (the "preferred shareholders") who own 49% of Levo common units. The preferred stock is not mandatorily redeemable or currently redeemable, but it could be redeemable with the passage of time at the election of Levo, the preferred shareholders or a trigger event as defined in the preferred stock agreement. As a result of the contingent put right available to the preferred shareholders, the redeemable non-controlling interests in Levo are classified outside of permanent equity in the Company’s unaudited condensed consolidated balance sheets as mezzanine equity. The initial carrying value of the redeemable non-controlling interest is reported at the initial proceeds received on issuance date, reduced by the fair value of embedded derivatives resulting in an adjusted initial carrying value. The adjusted initial carrying value is further adjusted for the accretion of the difference with the redemption price value using the effective interest method. The accretion amount is a deemed dividend recorded against retained earnings or, in its absence, to additional-paid-in-capital. The carrying amount of the redeemable non-controlling interest is measured at the higher of the carrying amount adjusted each reporting period for income (or loss) attributable to the non-controlling interest, or the carrying amount adjusted each reporting period by the accretion amount. See Note 18 for details. Non-controlling interests The Company presents non-controlling interests as a component of equity on its condensed consolidated balance sheets and reports the portion of its earnings or loss for non-controlling interest as net earnings or loss attributable to non-controlling interests in the condensed consolidated statements of operations. Emerging Growth Company Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) permits emerging growth companies (“EGC”) to delay complying with new or revised financial accounting standards that do not yet apply to private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act). The Company qualifies as an EGC. The JOBS Act provides that an EGC can elect to opt-out of the extended transition period and comply with the requirements that apply to non-EGCs, but any such election to opt-out is irrevocable. The Company has elected not to opt-out of such an extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an EGC, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This different adoption timing may make a comparison of the Company’s financial statements with another public company, which is neither an EGC nor an EGC that has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used. COVID-19 The novel coronavirus (COVID-19) which was declared a pandemic in March 2020, and the related restrictive measures such as travel restrictions, quarantines, and shutdowns, has negatively impacted the global economy. As national and local governments in different countries ease COVID-19 restrictions, and vaccines are distributed and rolled out successfully, we continue to see improved economic trends. However, COVID-19 and actions taken to mitigate its spread have had and are expected to continue to have an adverse impact on the economies and financial markets of many countries, including the geographical area in which the Company operates. The Company continues to monitor the situation closely but, at this time, is unable to predict the cumulative impact, both in terms of severity and duration, that the coronavirus pandemic has and will have on its business, operating results, cash flows and financial condition, and it could be material if the current circumstances continue to exist for a prolonged period of time. In addition to any direct impact on Nuvve’s business, it is reasonably possible that the estimates made by management in preparing Nuvve’s financial statements have been, or will be, materially and adversely impacted in the near term as a result of the on-going COVID-19 conditions. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made by management include the impairment of intangible assets, the net realizable value of inventory, the fair value of share-based payments, the fair value of notes payable conversion options, revenue recognition, the fair value of warrants, and the recognition and disclosure of contingent liabilities. Management evaluates its estimates on an ongoing basis. Actual results could materially vary from those estimates. Cash and Restricted Cash The Company maintains cash balances that can, at times, exceed amounts insured by the Federal Deposit Insurance Corporation, which is up to $250,000. The Company has not experienced any losses in these accounts and believes it is not exposed to any significant credit risk in this area. Concentrations of Credit Risk At June 30, 2022 and December 31, 2021, the financial instruments which potentially expose the Company to concentration of credit risk consist of cash in financial institutions (in excess of federally insured limits) and trade receivables. The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable, as follows: For the three and six months ended June 30, 2022 three and two customers accounted for 54.9% and 58.8% of revenue, respectively. For the three and six months ended June 30, 2021 two and three customers in aggregate accounted for 48.6% and 56.4% of revenue, respectively. During the three and six months ended June 30, 2022, the Company's top five customers accounted for approximately 71.8% and 70.1%, respectively, o f the Company’s total revenue. During the three and six months ended June 30, 2021, the Company's top five customers accounted for approximately 68.3% and 71.0%, respectively, o f the Company’s total revenue. At June 30, 2022 , two customers in aggregate accounted f or 37.1% of accounts receivable. At December 31, 2021 , two customers in aggregate accounted for 32.2% of accounts receivable. Approximat ely 58.5% a nd 56.0% of the Company’s trade accounts receivable balance was with five customers at June 30, 2022 and December 31, 2021 , respectively. The Company estimates its maximum credit risk for accounts receivable at the amount recorded on the balance sheet. The trade accounts receivables are generally short-term and all probable bad debt losses have been appropriately considered in establishing the allowance for doubtful accounts. Revenue Recognition Bill-and-hold arrangements - The Company occasionally enter a bill and hold arrangements in which some customers request that billed products that are ready for delivery be held at our warehouse facility for them until shipment at a later date. In this instance, revenue is recognized when; 1) the risks of ownership, including title, have passed to the customer, 2) the product must be identified separately as belonging to the customer, 3) the product currently must be ready for physical transfer to the customer, and 4) the Company does not have the ability to use the product or to direct it to another customer. Investments in Equity Securities Without Readily Determinable Fair Values Investments in equity securities of nonpublic entities without readily determinable fair values are carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company reviews its equity securities without readily determinable fair values on a regular basis to determine if the investment is impaired. For purposes of this assessment, the Company considers the investee’s cash position, earnings and revenue outlook, liquidity, and management ownership, among other factors, in its review. If management’s assessment indicates that an impairment exists, the Company estimates the fair value of the equity investment and recognizes in current earnings an impairment loss that is equal to the difference between the fair value of the equity investment and its carrying amount. In June 2022, the Company invested $1.0 million in Switch EV Ltd ("Switch"), a nonpublic entity incorporated and registered in the United Kingdom for a future equity ownership. Since Switch is a nonpublic entity, there is no readily determinable fair value. As of June 30, 2022, the Company’s investment in Switch was accounted for as an investment in equity securities without a readily determinable fair value subject to impairment. The Company did not recognize an impairment loss on its investment during the quarter ended June 30, 2022. Recently adopted accounting pronouncements None. Recently issued accounting pronouncements not yet adopted In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326) – Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires, among other things, the use of a new current expected credit loss ("CECL") model in determining the allowances for doubtful accounts with respect to accounts receivable, accrued straight-line rents receivable, and notes receivable. The CECL model requires that an entity estimate its lifetime expected credit loss with respect to these receivables and record allowances that, when deducted from the balance of the receivables, represent the net amounts expected to be collected. Entities will also be required to disclose information about how the entity developed the allowances, including changes in the factors that influenced its estimate of expected credit losses and the reasons for those changes. This update is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.

Revenue Recognition

Revenue Recognition	6 Months Ended
Revenue Recognition	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition The disclosures below discuss the Company’s material revenue contracts. The following table provides information regarding disaggregated revenue based on revenue by service lines for the three and six months ended June 30: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Revenue recognized over time: Services $ 73,522 $ 363,366 $ 268,172 $ 530,611 Grants 233,698 214,814 350,947 701,943 Products 994,507 403,150 3,053,641 547,808 Total revenue $ 1,301,727 $ 981,330 $ 3,672,760 $ 1,780,362 The aggregate amount of revenue for the Company’s existing contracts and grants with customers as of June 30, 2022 expected to be recognized in the future, and classified as deferred revenue on the condensed consolidated Balance Sheet, for years ended December 31, is as follows (this disclosure does not include revenue related to contracts whose original expected duration is one year or less): 2022 (remaining six months) $ 138,399 Thereafter 643,523 Total $ 781,922 Segment Reporting The Company operates in a single business segment, which is the EV V2G Charging segment. The following table summarizes the Company’s revenues for the three and six months ended June 30, 2022 and 2021: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Revenues: United States $ 1,125,586 $ 812,796 $ 3,353,976 $ 1,404,627 United Kingdom 99,995 113,703 137,385 254,989 Denmark 76,146 54,831 181,399 120,746 $ 1,301,727 $ 981,330 $ 3,672,760 $ 1,780,362 The following table summarizes the Company’s long-lived assets in different geographic locations as of June 30, 2022 and December 31, 2021: June 30, December 31, Long-lived assets: United States $ 1,915,685 $ 1,811,607 Denmark 20,827 25,664 $ 1,936,512 $ 1,837,271

Fair Value Measurements

Fair Value Measurements	6 Months Ended
Fair Value Measurements	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following are the liabilities measured at fair value on the condensed consolidated balance sheet at June 30, 2022 using quoted price in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3): Level 1: Level 2: Level 3: Total at June 30, Total Gains (Losses) For The Three Months Ended June 30, 2022 Total Gains (Losses) For The Six Months Ended June 30, 2022 Recurring fair value measurements Private warrants $ — $ — $ 182,000 $ 182,000 $ 251,000 $ 684,000 Stonepeak and Evolve unvested warrants $ — $ — $ — $ — $ 4,334,000 $ 8,677,000 Derivative liability - non-controlling redeemable preferred shares $ — $ — $ 491,012 $ 491,012 $ (32,536) $ 20,936 Total recurring fair value measurements $ — $ — $ 673,012 $ 673,012 $ 4,552,464 $ 9,381,936 Level 1: Level 2: Level 3: Total at June 30, Total Gains (Losses) For The Three Months Ended June 30, 2021 Total Gains (Losses) For The Six Months Ended June 30, 2021 Recurring fair value measurements Private warrants $ — $ — $ 1,183,000 $ 1,183,000 $ (351,602) $ 70,228 Stonepeak and Evolve unvested warrants (As Restated) (1) $ — $ — $ 11,123,000 $ 11,123,000 $ (3,145,628) $ (3,145,628) Total recurring fair value measurements $ — $ — $ 12,306,000 $ 12,306,000 $ (3,497,230) $ (3,075,400) The following is a reconciliation of the opening and closing balances for the liabilities related to the warrants (Note 11) and derivative liability - non-controlling redeemable preferred shares measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and six months ended June 30, 2022: Private Warrants Stonepeak and Evolve unvested warrants Non-controlling redeemable preferred shares - derivative liability (As Restated) (1) Balance at December 31, 2021 $ 866,000 $ 8,677,000 $ 511,948 Total (gains) losses for period included in earnings (433,000) (4,343,000) (53,472) Balance at March 31, 2022 433,000 4,334,000 458,476 Total (gains) losses for period included in earnings (251,000) (4,334,000) 32,536 Balance at June 30, 2022 $ 182,000 $ — $ 491,012 The fair value of the level 3 Private Warrants was estimated at June 30, 2022 using the Black-Scholes model which used the following inputs: term of 3.72 years, risk free rate of 3.0%, no dividends, volatility of 67.0%, and strike price of $11.50. The fair value of the level 3 Private Warrants was estimated at June 30, 2021 using the Black-Scholes model which used the following inputs: term of 4.72 years, risk free rate of 0.80%, no dividends, volatility of 88.0%, and strike price of $11.50. The following table presents the significant unobservable inputs and valuation methodologies used for the Company’s fair value measurements of non-recurring (level 3) Stonepeak and Evolve unvested warrants at June 30, 2022 : Series C Unvested Warrants Series D Unvested Warrants Series E Unvested Warrants Series F Unvested Warrants Fair value (in millions) $— $— $— $— Valuation methodology Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Term (years) 8.90 8.90 8.90 8.90 Risk free rate 3.0% 3.0% 3.0% 3.0% Exercise price $15.0 $20.0 $30.0 $40.0 Volatility 56.0% 56.0% 56.0% 56.0% Capital expenditure forecast (in millions) $125.0 $250.0 $375.0 $500.0 Probability of warrants vesting (a) —% —% —% —% __________________ (a) During the second quarter ended June 30, 2022, the Company significantly lowered its forecast of Levo's capital deployments due to the passage by the United States Congress of the Infrastructure Investment and Jobs Act bill, and the related unveiling of the Environmental Protection Agency’s 2022 Clean School Bus rebates. The resulting lower forecast of capital deployments reduced the probabilities of the future vesting of the unvested warrants. The following table presents the significant unobservable inputs and valuation methodologies used for the Company’s fair value measurements of non-recurring (level 3) Stonepeak and Evolve unvested warrants at June 30, 2021: Series C Unvested Warrants Series D Unvested Warrants Series E Unvested Warrants Series F Unvested Warrants Fair value (in millions) $3.8 $3.1 $2.4 $1.9 Valuation methodology Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Term (years) 9.90 9.90 9.90 9.90 Risk free rate 1.4% 1.4% 1.4% 1.4% Exercise price $15.0 $20.0 $30.0 $40.0 Volatility 55.0% 55.0% 55.0% 55.0% Capital expenditure forecast (in millions) $125.0 $250.0 $375.0 $500.0 Probability of warrants vesting 97.1% 88.2% 78.8% 70.4% The fair value of the level 3 derivative liability - non-controlling redeemable preferred shares are estimated at June 30, 2022 using the M onte Carlo Simulation model which used the following inputs: terms range from 2.09 years years to 7.0 years, risk free rate of 3.0%, no dividends, volatility of 57.0% and probability of redemptions triggered of 75.0%. There were no transfers between Level 1 and Level 2 of the fair value hierarchy in 2022 and 2021. Cash, accounts receivable, accounts payable, and accrued expenses are generally carried on the cost basis, which management believes approximates fair value due to the short-term maturity of these instruments.

Derivative Liability - Non-Cont

Derivative Liability - Non-Controlling Redeemable Preferred Stock	6 Months Ended
	Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability - Non-Controlling Redeemable Preferred Stock	Derivative Liability - Non-Controlling Redeemable Preferred StockThe Company has determined that the redemption features embedded in the non-controlling redeemable preferred stock is required to be accounted for separately from the redeemable preferred stock as a derivative liability. Separation of the redemption features as a derivative liability is required because its economic characteristics and risks are considered more akin to a debt instrument, and therefore, not considered to be clearly and closely related to the economic characteristics of the redeemable preferred stock. The economic characteristics of the redemption features are considered more akin to an debt instrument because the minimum redemption value could be greater than the face amount, the redemption features are contingently exercisable, and the shares carry a fixed mandatory dividend. Accordingly, the Company has recorded an embedded derivative liability representing the estimated fair value of the right of the holders to exercise their redemption option upon the occurrence of a redemption event. The embedded derivative liability is adjusted to reflect fair value at each period end with changes in fair value recorded in the “Change in fair value of derivative liability” financial statement line item of the company’s consolidated statements of operations. For additional information on the non-controlling redeemable preferred stock, see Note 18 . The following table display the fair value of derivatives by balance sheet line item at June 30, 2022 and December 31, 2021: June 30, 2022 December 31, 2021 Other long term liabilities: Derivative liability - non-controlling redeemable preferred shares $ 491,012 $ 511,948

Investments

Investments	6 Months Ended
Investments	Jun. 30, 2022
Investments [Abstract]
Investment in Dreev	Investments The Company accounts for its 13% equity ownership in Dreev as an investment in equity securities without a readily determinable fair value subject to impairment. The Company has a consulting services agreement with Dreev related to software development and operations. The consulting services were zero fo r each of the three and six months ended June 30, 2022 and 2021. The consulting services are being provided to Dreev at the Company’s cost and is recognized, net of consulting costs, as other income, net in the condensed consolidated statements of operations. In accordance with an advanced subscription agreement dated June 6, 2022, the Company invested $1.0 million in Switch, a nonpublic entity incorporated and registered in the United Kingdom for a future equity ownership expected be more or less than 5% subject to final valuations. Switch will automatically award the Company the equity ownership with conversion shares in equity upon its completion of either a financing round, company sale or IPO, or dissolution event. The Company is expected to account for the investment as an investment in equity securities without a readily determinable fair value subject to impairment. The Company and Switch intends to collaborate in the future to integrate technologies for the advancement of V2G.

Account Receivables, Net

Account Receivables, Net	6 Months Ended
Account Receivables, Net	Jun. 30, 2022
Receivables [Abstract]
Account Receivables, Net	Account Receivables, Net The following tables summarizes the Company's accounts receivable on the consolidated balance sheets at June 30, 2022 and December 31, 2021: June 30, 2022 December 31, 2021 Trade receivables $ 2,021,844 $ 1,949,896 Less: allowance for doubtful accounts (63,188) (63,188) Accounts receivable, net $ 1,958,656 $ 1,886,708 Allowance for doubtful accounts: Balance December 31, 2021 $ (63,188) Provision — Write-off — Recoveries — Balance June 30, 2022 $ (63,188)

Inventories

Inventories	6 Months Ended
Inventories	Jun. 30, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories The following table summarizes the Company’s inventories balance by category: June 30, 2022 December 31, 2021 DC Chargers $ 8,852,624 $ 7,687,598 AC Chargers 214,486 232,920 Vehicles - School Buses (1) 1,620,000 3,180,000 Others 108,922 17,670 Total $ 10,796,032 $ 11,118,188 __________________ (1) As of June 30, 2022, the Company has taken delivery of ten school buses it has committed to purchase from the manufacturer within one year from the purchase order date of May 26, 2021. Five school buses were sold during first quarter ended March 31, 2022.

Property, Plant and Equipment

Property, Plant and Equipment	6 Months Ended
Property, Plant and Equipment	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment The following table summarizes the Company’s property, plant and equipment balance at June 30, 2022 and December 31, 2021: June 30, 2022 December 31, 2021 Computers & Servers $ 126,931 $ 105,499 Vehicles 168,862 168,862 Office furniture and equipment 332,007 161,771 Others 131,607 6,050 Total 759,407 442,182 Less: Accumulated Depreciation (158,861) (85,988) Property, plant and equipment, net $ 600,546 $ 356,194 June 30, 2022 June 30, 2021 Depreciation expense $ 62,265 $ 12,147

Intangible Assets

Intangible Assets	6 Months Ended
Intangible Assets	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets At both June 30, 2022 and December 31, 2021, the Company had recorded a gross intangible asset balance of $2,091,556, which is related to patent and intangible property rights acquired. Amortization expense of intangible assets was $34,860 each for the three months ended June 30, 2022 and 2021, respectively. Amortization expense of intangible assets was $69,720 each for the six months ended June 30, 2022 and 2021, respectively. Accumulated amortization totaled $680,200 and $610,480 at June 30, 2022 and December 31, 2021, respectively. The net amount of intangible assets of $1,411,358 at June 30, 2022, will be amortized over the weighted average remaining life of 10.4 years . Total estimated future amortization expense is as follows: 2022 (remaining six months) $ 69,719 2023 139,437 2024 139,437 2025 139,437 2026 139,437 Thereafter 783,891 $ 1,411,358

Stockholders_ Equity

Stockholders’ Equity	6 Months Ended
Stockholders’ Equity	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Stockholders’ Equity	Stockholders’ Equity As of June 30, 2022, the Company has authorized two classes of stock, Common Stock, and Preferred Stock. The total number of shares of all classes of capital stock which the Company has authority to issue is 101,000,000, of which 100,000,000 authorized shares are Common Stock with a par value of $0.0001 per share (“Common Stock”), and 1,000,000 authorized shares are Preferred Stock of the par value of $0.0001 per share (“Preferred Stock”). Please see Note 12, “ Stockholders' Equity ,” in the Notes to Consolidated Financial Statements included in the Company’s 2021 Form 10-K for a detailed discussion of the Company’s stockholders' equity. Additionally, see Note 19, “Levo Mobility LLC Entity,” in the Notes to Consolidated Financial Statements included in the Company’s 2021 Form 10-K for a detailed discussion of the Company’s Stonepeak and Evolve Warrants and Securities Purchase agreement, and Levo definitive agreements. Shelf Registration and At the Market Offering On April 25, 2022, the Company filed a shelf registration statement with the SEC which will allow it to issue unspecified amounts of common stock, preferred stock, warrants for the purchase of shares of common stock or preferred stock, debt securities, and units consisting of any combination of any of the foregoing securities, in one or more series, from time to time and in one or more offerings up to a total dollar amount of $100.0 million. The shelf registration statement was declared effective on May 5, 2022. The Company believes that it will be able to raise capital by issuing securities pursuant to its effective shelf registration statement. On May 5, 2022, the Company entered into an at-the-market offering agreement, with Craig-Hallum Capital Group LLC and Chardan Capital Markets, LLC (the "Agent"). From time to time during the term of the Sales Agreement, the Company may offer and sell shares of common stock having an aggregate offering price up to a total of $25.0 million in gross proceeds. The Agents will collect a fee equal to 3% of the gross sales price of all shares of common stock sold. Shares of common stock sold under the Sales Agreement are offered and sold pursuant to our shelf registration statement describe above. During the six months ended June 30, 2022, the Company sold 323,746 shares of common stock pursuant to the Sales Agreement at an average price of $6.12 per share for aggregate net proceeds of approximately $1.9 million. Warrants - Stonepeak and Evolve On May 17, 2021, in connection with the signing of a letter of agreement, relating to the formation of Levo (the "Letter Agreement"), the Company issued to Stonepeak and Evolve a ten years warrants to purchase common stock (allocated 90% to Stonepeak and 10% to Evolve). See below for details. The grant-date fair value of the warrants issued to Stonepeak and Evolve were; series B $12.8 million, series C $5.6 million, series D $4.8 million, series E $3.8 million and series F $3.2 million. The fair values of the vested warrants are recorded in the consolidated balance sheets in additional-paid-in capital in stockholders' equity as the vested warrants are indexed to the Company’s common stock and meet the conditions for equity classification. The unvested warrants are recorded as a liability in the consolidated balance sheet at fair value, with changes in fair value recorded in the consolidated statement of operations, as the unvested warrants are deemed not to be indexed to the Company’s common stock. See Note 4 for details of changes in fair value of the unvested warrants recorded in the consolidated statement of operations. In connection with the signing of the Letter Agreement, the Company issued to Stonepeak and Evolve the following ten years warrants to purchase common stock (allocated 90% to Stonepeak and 10% to Evolve): • Series B warrants to purchase 2,000,000 shares of the Company’s common stock, at an exercise price of $10.00 per share, which are fully vested upon issuance, • Series C warrants to purchase 1,000,000 shares of the Company’s common stock, at an exercise price of $15.00 per share, which are vested as to 50% of the shares upon issuance and vest as to the remaining 50% when Levo has entered into contracts with third parties for $125 million in aggregate capital expenditures, • Series D warrants to purchase 1,000,000 shares of the Company’s common stock, at an exercise price of $20.00 per share, which are vested as to 50% of the shares upon issuance and vest as to the remaining 50% when Levo has entered into contracts with third parties for $250 million in aggregate capital expenditures, • Series E warrants to purchase 1,000,000 shares of the Company’s common stock, at an exercise price of $30.00 per share, which are vested as to 50% of the shares upon issuance and vest as to the remaining 50% when Levo has entered into contracts with third parties for $375 million in aggregate capital expenditures, and • Series F warrants to purchase 1,000,000 shares of the Company’s common stock, at an exercise price of $40.00 per share, which are vested as to 50% of the shares upon issuance and vest as to the remaining 50% when Levo has entered into contracts with third parties for $500 million in aggregate capital expenditures. The warrants may be exercised at any time on or after the date that is 180 days after the applicable vesting date. Warrants - Public and Private In connection with its initial public offering on February 19, 2020, Newborn sold 5,750,000 units, which included one warrant to purchase Newborn’s common stock (the “Public Warrants”). Also, on February 19, 2020, NeoGenesis Holding Co., Ltd., Newborn’s sponsor (“the Sponsor”), purchased an aggregate of 272,500 private units, each of which included one warrant (the “Private Warrants”), which have the same terms as the Public Warrants. Upon completion of the merger between Nuvve and Newborn, the Public Warrants and Private Warrants were automatically converted to warrants to purchase Common Stock of the Company. The terms of the Private Warrants are identical to the Public Warrants as described above, except that the Private Warrants are not redeemable so long as they are held by the Sponsor or its permitted transferees. Concurrently with the execution of the Merger Agreement on November 11, 2020, Newborn entered into subscription agreements with certain accredited investors pursuant to which the investors agreed to purchase 1,425,000 of Newborn’s common stock, at a purchase price of $10.00 per share, for an aggregate purchase price of $14,250,000 (the "PIPE"). Upon closing of the PIPE immediately prior to the closing of the Business Combination, the PIPE investors also received 1.9 PIPE Warrants to purchase the Company’s Common Stock for each share of Common Stock purchased. The PIPE Warrants are each exercisable for one-half of a common share at $11.50 per share and have the same terms as described above for the Public Warrants. The PIPE investors received demand and piggyback registration rights in connection with the securities issued to them. The following table is a summary of the number of shares of the Company’s Common Stock issuable upon exercise of warrants outstanding at June 30, 2022 (there were no warrants outstanding at December 31, 2021): Number of Number of Exercise Expiration Public Warrants 2,875,000 2,875,000 $11.50 March 19, 2026 Private Warrants 136,250 136,250 $11.50 March 19, 2026 PIPE Warrants 1,353,750 1,353,750 $11.50 March 19, 2026 Stonepeak/Evolve Warrants - series B 2,000,000 2,000,000 $10.00 May 17, 2031 Stonepeak/Evolve Warrants - series C 1,000,000 500,000 $15.00 May 17, 2031 Stonepeak/Evolve Warrants - series D 1,000,000 500,000 $20.00 May 17, 2031 Stonepeak/Evolve Warrants - series E 1,000,000 500,000 $30.00 May 17, 2031 Stonepeak/Evolve Warrants - series F 1,000,000 500,000 $40.00 May 17, 2031 10,365,000 8,365,000 Because the Private Warrants have dissimilar terms with respect to the Company’s redemption rights depending on the holder of the Private Warrants, the Company determined that the Private Warrants are required to be carried as a liability in the condensed consolidated balance sheet at fair value, with changes in fair value recorded in the condensed consolidated statement of operations. The Private Warrants are reflected as a liability in the condensed consolidated balance sheet as of June 30, 2022 in the amount of $182,000 and the change in the fair value of the Private Warrants for the three and six months ended June 30, 2022 of is reflect ed as a gain of $251,000 and $684,000, resp ectively, in the condensed consolidated statement of operations. Unit Purchase Option On February 19, 2020, Newborn sold to the underwriters of its initial public offering for $100, a unit purchase option ("UPO") to purchase up to a total of 316,250 units at $11.50 per unit (or an aggregate exercise price of $3,636,875) commencing on the date of Newborn's initial business combination, March 19, 2021, and expiring February 13, 2025. Each unit issuable upon exercise of the UPO consists of one and one-tenth of a share of the Company's common stock and one warrant to purchase one share of the Company's common stock at the exercise price of $11.50 per share. The warrant has the same terms as the Public Warrant. In no event will the Company be required to net cash settle the exercise of the UPO or the warrants underlying the UPO. The holders of the unit purchase option have demand and "piggy back" registration rights for periods of five ASC 815-40, Derivatives and Hedging-Contracts in an Entity’s Own Equity, as the UPO is indexed to the Company’s common stock and meets the conditions for equity classification. Securities Purchase Agreement On May 17, 2021, in connection with the signing of the Letter Agreement, the Company entered into a Securities Purchase Agreement with Stonepeak and Evolve which provide them from time to time between November 13, 2021 and November 17, 2028, in their sole discretion, to purchase up to an aggregate of $250 million in shares of the Company’s common stock at a purchase price of $50.00 per share (allocated 90% to Stonepeak and 10% to Evolve). See below f or details. The grant-date fair value of the Securities Purchase Agreement to purchase shares of the Company’s common stock was $12.6 million, and is recorded in the condensed consolidated balance sheet as equity in additional-paid-in capital as it is indexed to the Company’s common stock and meets the conditions for equity classification. In connection with the signing of the Letter Agreement, as reference above, the Company also entered into a Securities Purchase Agreement (the “SPA”) and a Registration Rights Agreement (the “RRA”) with Stonepeak and Evolve. • Under the SPA, from time to time between November 13, 2021 and November 17, 2028, Stonepeak and Evolve may elect, in their sole discretion, to purchase up to an aggregate of $250 million in shares of the Company’s common stock at a purchase price of $50.00 per share (allocated 90% to Stonepeak and 10% to Evolve). The SPA includes customary representations and warranties and closing conditions and customary indemnification provisions. In addition, Stonepeak and Evolve may elect to purchase shares under the SPA on a cashless basis in the event of a change of control of the Company.

Stock Option Plan

Stock Option Plan	6 Months Ended
Stock Option Plan	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
Stock Option Plan	Stock Option Plan In 2010, the Company adopted the 2010 Equity Incentive Plan (the “2010 Plan”), which provides for the grant of restricted stock awards, stock options, and other share-based awards to employees, consultants, and directors. In November 2020, the Company’s Board of Directors extended the term of the 2010 Plan to July 1, 2021. In 2021, the Company adopted the 2020 Equity Incentive Plan (the “2020 Plan”), which provides for the grant of restricted stock awards, incentive and non-statutory stock options, and other share-based awards to employees, consultants, and directors. As of June 30, 2022, there is an aggregate of 3,300,000 common shares reserved for issuance under the 2020 Plan. All options granted to date have a ten years contractual life and vesting terms of four years. In general, vested options expire if not exercised at termination of service. As of June 30, 2022, a total of 1,262,865 shares of common stock remained available for future issuance under the 2020 Plan. Stock-based compensation expense for the three and six months ended June 30 are as follows Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Options $ 548,652 $ 810,738 $ 1,370,758 $ 1,063,008 Restricted stock 1,187,254 258,137 1,801,093 267,972 Total $ 1,735,906 $ 1,068,875 $ 3,171,851 $ 1,330,980 The Company uses the Black-Scholes option pricing model to estimate the fair value of stock options. Fair value is estimated at the date of grant for employee and nonemployee options. The following assumptions were used in the Black-Scholes model to calculate the fair value of stock options granted for the six months ended June 30, 2022 for the 2010 Plan and the 2020 Plan. 2010 Plan 2020 Plan Expected life of options (in years) (1) 6.1 6.1 Dividend yield (2) 0 % 0 % Risk-free interest rate (3) 2.00 % 2.00 % Volatility (4) 54.1 % 54.1 % __________________ (1) The expected life of options is the average of the contractual term of the options and the vesting period. (2) No cash dividends have been declared on the Company’s common stock since the Company’s inception, and the Company currently does not anticipate declaring or paying cash dividends over the expected life of the options. (3) The risk-free interest rate is based on the yields on U.S. Treasury debt securities with maturities approximating the estimated life of the options. (4) Volatility is estimated by management. As the Company has been a private company for most of its existence, there is not enough historical volatility data related to the Company’s Common stock as a public entity. Therefore, this estimate is based on the average volatility of certain public company peers within the Company’s industry. The following is a summary of the stock option activity under the 2010 Plan, as converted to the Company’s shares due to Reverse Recapitalization, for the six months ended June 30, 2022: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2021 1,035,035 3.21 5.90 5,688,201 Granted — — — — Exercised (42,729) 2.42 — — Forfeited (36,065) 7.61 — — Expired/Cancelled (5,310) 1.37 — — Outstanding - June 30, 2022 950,931 3.09 5.24 2,264,735 Options Exercisable at June 30, 2022 836,687 2.52 4.84 2,257,456 Option Vested at June 30, 2022 836,687 2.52 4.84 2,257,456 The weighted-average grant-date fair value of options granted during the six months ended June 30, 2022 was zero. The following is a summary of the stock option activity under the 2020 Plan for the six months ended June 30, 2022: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2021 1,602,850 13.18 9.27 46,920 Granted 121,100 6.87 9.86 — Exercised — — — — Forfeited (128,450) 10.18 — — Expired/Cancelled (1,250) 8.25 — — Outstanding - June 30, 2022 1,594,250 12.84 8.83 — Options Exercisable at June 30, 2022 422,327 13.38 8.74 — Option Vested at June 30, 2022 422,327 13.38 8.74 — The weighted-average grant-date fair value of options granted during the six months ended June 30, 2022 was $3.55. During the year ended December 31, 2021 1,640,000 options were modified to lower the exercise price by $0.60 per share, which will result in $246,000 of incremental compensation cost to be recognized over the remaining vesting period. The amount of additional compensation expense for the three and six months ended June 30, 2022, w ere $25,459 and $45,158, respectively. The amount of additional compensation expense for the three and six months ended June 30, 2021, were $21,728 for both periods. Other Information: Six Months Ended 2022 2021 Amount received from option exercised $ 173,575 $ — June 30, 2022 Weighted average remaining recognition period Total unrecognized options compensation costs $ 7,767,742 2.80 No amounts relating to the Plan have been capitalized. Compensation cost is recognized over the requisite service period based on the fair value of the options. A summary of the status of the Company’s nonvested restricted stock units as of December 31, 2021, and changes during the six months ended June 30, 2022, is presented below: Shares Weighted- Nonvested at December 31, 2021 353,817 11.00 Granted 134,575 6.16 Vested/Release (202,141) 11.15 Cancelled/Forfeited (6,294) 9.93 Nonvested and Outstanding at June 30, 2022 279,957 8.60 As of June 30, 2022, there was $1,668,498 of total unrecognized compensation cost related to nonvested restricted stock. The Company expects to recognize this compensation cost over a remaining weighted-average period of approximately 1.9 years.

Income Taxes

Income Taxes	6 Months Ended
Income Taxes	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Income tax (benefit) expense $ — $ 1,000 $ — $ 1,000 Effective tax rate 0.0 % 0.0 % 0.0 % 0.0 % The effective tax rate used for interim periods is the estimated annual effective tax rate, based on current estimate of full year results, except that taxes related to specific events, if any, are recorded in the interim period in which they occur. The effective tax rate differed from the U.S. federal statutory tax rate primarily due to operating losses that receive no tax benefit as a result of a valuation allowance recorded for such losses. The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes (“ASC 740”). Under the provisions of ASC 740, management is required to evaluate whether a valuation allowance should be established against its deferred tax assets. The Company currently has a full valuation allowance against its deferred tax assets. As of each reporting date, the Company’s management considers new evidence, both positive and negative, that could impact management’s view with regard to future realization of deferred tax assets. For the six months ended June 30, 2022, there was no material change from the year ended December 31, 2021 in the amount of the Company’s deferred tax assets that are not considered to be more likely than not to be realized in future years.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	6 Months Ended
Net Loss Per Share Attributable to Common Stockholders	Jun. 30, 2022
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The following table sets forth the calculation of basic and diluted net loss per share attributable to common stockholders during the three and six months ended June 30, 2022 and 2021: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Net loss attributable to Nuvve common stockholders $ (5,494,918) $ (53,150,934) $ (10,350,727) $ (58,512,654) Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted 19,064,854 18,668,009 18,965,167 14,560,862 Net Loss per share attributable to Nuvve common stockholders, basic and diluted $ (0.29) $ (2.85) $ (0.55) $ (4.02) The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net loss per share attributable to Nuvve common stockholders because their effect would have been anti-dilutive: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Stock options issued and outstanding 2,688,173 2,505,711 2,858,756 1,792,556 Nonvested restricted stock issued and outstanding 869,945 677,543 867,793 582,148 Public warrants 2,875,000 2,875,000 2,875,000 1,627,060 Private warrants 136,250 136,250 136,250 77,109 PIPE warrants 1,353,750 1,353,750 1,353,750 766,133 Stonepeak and Evolve warrants 6,000,000 2,901,099 6,000,000 1,450,549 Stonepeak and Evolve options 5,000,000 2,417,582 5,000,000 1,208,791 Total 18,923,118 12,866,935 19,091,549 7,504,346

Related Parties

Related Parties	6 Months Ended
Related Parties	Jun. 30, 2022
Related Party Transactions [Abstract]
Related Parties	Related Parties As described in Note 6 , the Company holds equity interests in and provides certain consulting services to Dreev, an entity in which a stockholder of the Company owns the other portion of Dreev’s equity interests. During the three and six months ended June 30, 2022 the Company recognized re venue of zero and $28,000, respectively, from an entity that is an investor in the Company. During the three and six months ended June 30, 2021, the Company recognized re venue of $252,000 and $399,620, respectively, from an entity that is an investor in the Company. The Company had a balance of accounts receivable of zero at June 30, 2022 from the same entity that is an investor in the Company. Equity Forward Purchase

Leases

Leases	6 Months Ended
Leases	Jun. 30, 2022
Leases [Abstract]
Leases	Leases The Company has entered into leases for commercial office spaces and vehicles. These leases are not unilaterally cancellable by the Company, are legally enforceable, and specify fixed or minimum amounts. The leases expire at various dates through 2026 and provide for renewal options. In the normal course of business, it is expected that these leases will be renewed or replaced by leases on other properties. The leases provide for increases in future minimum annual rental payments based on defined increases in the Consumer Price Index, subject to certain minimum increases. Also, the agreements generally require the Company to pay real estate taxes, insurance, and repairs. On November 3, 2021, the Company entered into an amendment of its Main Office Lease to include an additional 4,811 rentable square feet in the suite adjoining its main office facilities in San Diego, California. The lease term will run concurrently with the main office lease which commenced in December 2021. The lease terms include 3% annual fixed increases in the base rental payment. The lease also requires the Company to pay operating expenses such as utilities, real estate taxes, insurance, and repairs. The lease term commenced on April 15, 2022, and the Company will receive two months of rental abatement to the base rent. Supplemental unaudited consolidated balance sheet information related to leases is as follows: Classification June 30, 2022 Operating lease assets Right-of-use operating lease assets $ 5,195,474 Finance lease assets Property, plant and equipment, net 20,827 Total lease assets $ 5,216,301 Operating lease liabilities - current Operating lease liabilities - current $ 455,064 Operating lease liabilities - noncurrent Operating lease liabilities - noncurrent 5,053,219 Finance lease liabilities - current Other liabilities - current 7,022 Finance lease liabilities - noncurrent Other long-term liabilities 15,120 Total lease liabilities $ 5,530,425 The components of lease expense are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2022 2021 2022 2021 Operating lease expense Selling, general and administrative $ 164,076 $ 33,396 $ 340,597 $ 91,827 Finance lease expense: Amortization of finance lease assets Selling, general and administrative 1,451 2,190 7,391 2,190 Interest on finance lease liabilities Interest expense 599 510 1,238 510 Total lease expense $ 166,126 $ 36,096 $ 349,226 $ 94,527 Operating Lease Finance Lease Maturities of lease liabilities are as follows: June 30, 2022 June 30, 2022 2022 $ 127,621 $ 3,511 2023 792,918 7,022 2024 824,712 7,022 2025 822,352 7,022 2026 847,022 — Thereafter 4,631,866 1,755 Total lease payments 8,046,491 26,332 Less: interest (2,538,208) (4,190) Total lease obligations $ 5,508,283 $ 22,142 Lease term and discount rate: June 30, 2022 Weighted-average remaining lease terms (in years): Operating lease 9.5 Finance lease 3.8 Weighted-average discount rate: Operating lease 7.8% Finance lease 7.8% Other Information: Six Months Ended June 30, Six Months Ended June 30, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 80,869 $ 94,818 Operating cash flows from finance leases $ 1,238 $ 510 Financing cash flows from finance leases $ 4,425 $ 1,989 Leased assets obtained in exchange for new finance lease liabilities $ 20,827 $ 29,977 Leased assets obtained in exchange for new operating lease liabilities $ — $ — Sublease In April 2022, the Company entered into a sublease agreement with certain local San Diego companies to sublease the Company's portion of the 4,811 square foot expansion. The term of the sublease is six months to twelve months with fixed base rental income of $2,250 per month. The sublease has no option for renewal or extension at the end of the sublease term. Sublease income are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2022 2021 2022 2021 Sublease lease income Other, net $ 20,125 $ — $ 20,125 $ —
Leases	Leases The Company has entered into leases for commercial office spaces and vehicles. These leases are not unilaterally cancellable by the Company, are legally enforceable, and specify fixed or minimum amounts. The leases expire at various dates through 2026 and provide for renewal options. In the normal course of business, it is expected that these leases will be renewed or replaced by leases on other properties. The leases provide for increases in future minimum annual rental payments based on defined increases in the Consumer Price Index, subject to certain minimum increases. Also, the agreements generally require the Company to pay real estate taxes, insurance, and repairs. On November 3, 2021, the Company entered into an amendment of its Main Office Lease to include an additional 4,811 rentable square feet in the suite adjoining its main office facilities in San Diego, California. The lease term will run concurrently with the main office lease which commenced in December 2021. The lease terms include 3% annual fixed increases in the base rental payment. The lease also requires the Company to pay operating expenses such as utilities, real estate taxes, insurance, and repairs. The lease term commenced on April 15, 2022, and the Company will receive two months of rental abatement to the base rent. Supplemental unaudited consolidated balance sheet information related to leases is as follows: Classification June 30, 2022 Operating lease assets Right-of-use operating lease assets $ 5,195,474 Finance lease assets Property, plant and equipment, net 20,827 Total lease assets $ 5,216,301 Operating lease liabilities - current Operating lease liabilities - current $ 455,064 Operating lease liabilities - noncurrent Operating lease liabilities - noncurrent 5,053,219 Finance lease liabilities - current Other liabilities - current 7,022 Finance lease liabilities - noncurrent Other long-term liabilities 15,120 Total lease liabilities $ 5,530,425 The components of lease expense are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2022 2021 2022 2021 Operating lease expense Selling, general and administrative $ 164,076 $ 33,396 $ 340,597 $ 91,827 Finance lease expense: Amortization of finance lease assets Selling, general and administrative 1,451 2,190 7,391 2,190 Interest on finance lease liabilities Interest expense 599 510 1,238 510 Total lease expense $ 166,126 $ 36,096 $ 349,226 $ 94,527 Operating Lease Finance Lease Maturities of lease liabilities are as follows: June 30, 2022 June 30, 2022 2022 $ 127,621 $ 3,511 2023 792,918 7,022 2024 824,712 7,022 2025 822,352 7,022 2026 847,022 — Thereafter 4,631,866 1,755 Total lease payments 8,046,491 26,332 Less: interest (2,538,208) (4,190) Total lease obligations $ 5,508,283 $ 22,142 Lease term and discount rate: June 30, 2022 Weighted-average remaining lease terms (in years): Operating lease 9.5 Finance lease 3.8 Weighted-average discount rate: Operating lease 7.8% Finance lease 7.8% Other Information: Six Months Ended June 30, Six Months Ended June 30, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 80,869 $ 94,818 Operating cash flows from finance leases $ 1,238 $ 510 Financing cash flows from finance leases $ 4,425 $ 1,989 Leased assets obtained in exchange for new finance lease liabilities $ 20,827 $ 29,977 Leased assets obtained in exchange for new operating lease liabilities $ — $ — Sublease In April 2022, the Company entered into a sublease agreement with certain local San Diego companies to sublease the Company's portion of the 4,811 square foot expansion. The term of the sublease is six months to twelve months with fixed base rental income of $2,250 per month. The sublease has no option for renewal or extension at the end of the sublease term. Sublease income are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2022 2021 2022 2021 Sublease lease income Other, net $ 20,125 $ — $ 20,125 $ —

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies (a) Legal Matters The Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities, including product liability claims. Management believes that any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the financial condition or results of operations of the Company. (b) Research Agreement Effective September 1, 2016, the Company is party to a research agreement with a third party, which is also a Company stockholder, whereby the third party will perform research activity as specified annually by the Company. Under the terms of the agreement, the Company paid a minimum of $400,000 annually in equal quarterly installments. For the six months ended June 30, 2022 and 2021, $200,000 each was paid under the research agreement, respectively. In October 2021, the agreement was renewed for one year through August 2022. At June 30, 2022, $66,667 remained to be paid under the renewed agreement. (c) In-Licensing The Company is a party to a licensing agreement for non-exclusive rights to intellectual property which will expire at the later of the date at which the last patent underlying the intellectual property expires or 20 years from the sale of the first licensed product. Under the terms of the agreement, the Company will pay up to an aggregate of $700,000 in royalties upon achievement of certain milestones. As of June 30, 2022 and December 31, 2021, no royalty expenses had been incurred under this agreement . In November 2017, the Company executed an agreement ("IP Acquisition Agreement") with the University of Delaware (Seller) whereby all right, title, and interest in the licensed intellectual property was assigned to the Company in exchange for an upfront fee of $500,000 and common shares valued at $1,491,556. The total acquisition cost of $1,991,556 was capitalized and is being amortized over the fifteen years expected life of the patents underlying the intellectual property. Under the terms of the agreement, the Company will pay up to an aggregate $7,500,000 in royalties to the Seller upon achievement of milestones, related to the aggregate number of vehicles that have had access to the Company’s GIVe platform system for a period of at least six consecutive months, and for which the Company has received monetary consideration for such access pursuant to a subscription or other similar agreement with the vehicle’s owner as follows: Milestone Event: Aggregated Vehicles Milestone 10,000 $ 500,000 20,000 750,000 40,000 750,000 60,000 750,000 80,000 750,000 100,000 1,000,000 200,000 1,000,000 250,000 2,000,000 $ 7,500,000 The Seller will retain a non-exclusive, royalty-free license, to utilize the intellectual property solely for research and education purposes. As of June 30, 2022, no royalty expenses had been incurred under this agreement. (d) Investment The Company is committed to possible future additional contributions to the Investment in Dreev ( Note 6 ) in the amount of $270,000. (e) Purchase Commitments On July 20, 2021, Nuvve issued a purchase order (“PO”) to its supplier for a quantity of DC Chargers, for a total price of $13.2 million, with the delivery date specified as the week of November 15, 2021. However, the supplier subsequently notified Nuvve that it would be unable to meet the contracted delivery date as a result of supply chain issues. The parties therefore agreed to change the delivery date to on or about December 15, 2021. As of the end of June 30, 2022 , Nuvve received a partial shipment of the DC Chargers, for which Nuvve paid $5.3 million. The delivered DC Chargers did not fully conform to required software and hardware specifications. As of June 30, 2022 , the supplier is still in the process of bringing the delivered DC Chargers into full conformance. In April 2022, the parties agreed to address the technical issues necessary to bring the DC charges into full conformity with specifications, and to amend the mix defined in original PO for the delivery of the remaining DC Chargers still subject to the original PO. No amendments to the original PO have been executed. To the extent Nuvve and the supplier are unable to align on mutually agreeable terms to resolve the dispute relating to the PO, Nuvve believes it has no obligation to purchase or accept delivery against the PO given that the supplier failed to timely deliver conforming DC Chargers in accordance with the stated PO terms. The supplier asserts, however, that the original PO was non-cancellable and non-refundable regardless of when in the future the chargers are delivered, and regardless of any non-conformance. Nuvve believes the supplier’s position does not have merit and Nuvve would exercise all available rights and remedies in its defense should any legal proceeding result from such dispute. The outcome of any such proceeding would be inherently uncertain, and the amount and/or timing of any liability or expense resulting from such a proceeding is not reasonably estimable at this time.

Non-Controlling Interest

Non-Controlling Interest	6 Months Ended
Non-Controlling Interest	Jun. 30, 2022
Noncontrolling Interest [Abstract]
Non-Controlling Interest	Non-Controlling Interest For entities that are consolidated, but not 100% owned, a portion of the net income or loss and corresponding equity is allocated to owners other than the Company. The aggregate of the net income or loss and corresponding equity that is not owned by the Company is included in non-controlling interests in the condensed consolidated financial statements. Non-controlling interests are presented outside as a separate component of stockholders’ equity on the Company’s condensed consolidated Balance Sheets. The primary components of non-controlling interests are separately presented in the Company’s condensed consolidated statements of changes in stockholders’ equity to clearly distinguish the interest in the Company and other ownership interests in the consolidated entities. Net income or loss includes the net income or loss attributable to the holders of non-controlling interests on the Company’s condensed consolidated statements of operations. Net income or loss is allocated to non-controlling interests in proportion to their relative ownership interests. Levo Series B Redeemable Preferred Stock Levo is authorized to issue 1,000,000 shares of series B preferred stock at no par value. The Series B Preferred Stock (a) pays a dividend, when, as and if declared by Levo's Board of Directors, of 8.0% per annum of the stated value per share, payable quarterly in arrears, (b) has an initial stated value of $1,000 per share, and dividends are paid in cash. Levo accrues for undeclared and unpaid dividends as they are payable in accordance with the terms of the Certificate of Designations filed with the Secretary of State of the State of Delaware. At June 30, 2022, Levo had accrued preferred dividends of $192,071 on 3,138 issued and outstanding shares of Series B Preferred Stock. Series B Preferred Stock is not a participating or convertible securities. Series B Preferred Stock is not currently redeemable but it could be redeemable with the passage of time at the election of Levo or the preferred shareholders or upon the occurrence of a trigger event as defined in the preferred stock agreement. Since the redeemable preferred stock may be redeemed by the preferred shareholders or upon the occurrence of a trigger event that is not solely within the control of Levo, but is not mandatorily redeemable; therefore, based on its characteristics, Levo has classified the Series B Preferred Stock as mezzanine equity. At June 30, 2022, Series B Preferred Stock consisted of the following: Shares Authorized Shares Issued and Outstanding Stated Value per Share Initial Carrying Value Accrued Preferred Dividends Liquidation Preference 1,000,000 3,138 $ 1,000 $ 3,138,000 $ 192,071 $ 3,330,071 The Company has determined that the redemption features embedded in the non-controlling redeemable preferred stock is required to be accounted for separately from the redeemable preferred stock as a derivative liability. See Note 5 for detail disclosure of the derivative liability. The redeemable preferred stock has been classified as mezzanine equity and initially recognized at fair value of $3,138,000, the proceeds on the date of issuance. This amount has been further reduced by $497,606, the fair value of the embedded derivative liability at date of issuance, resulting in an adjusted initial value of $2,640,394. Levo is accreting the difference between the adjusted carrying initial value and the redemption price value over the seven-year period from date of issuance of August 4, 2021 through July 4, 2028 (the date at which the preferred shareholders have the unconditional right to redeem the shares, deemed to be the earliest likely redemption date) using the effective interest method. The accretion to the carrying value of the redeemable preferred stock is treated as a deemed dividend, recorded as a charge to retained earnings of Levo. During the six months ended June 30, 2022, Levo accreted $322,932 resulting in the carrying value of the the redeemable preferred stock of $3,224,832. The following table summarizes Levo non-controlling interests presented as a separate component of stockholders’ equity on the Company’s condensed consolidated balance sheets at June 30, 2022: June 30, 2022 (As Restated) (1) Add: net loss attributable to non-controlling interests as of June 30, 2022 $ (290,878) Less: dividends paid to non-controlling interests as of June 30, 2022 129,311 Less: Preferred share accretion adjustment as of June 30, 2022 322,932 Non-controlling interests $ (743,121) The following table summarizes Levo non-controlling interests presented as a separate component of the Company’s condensed consolidated statements of operations as of June 30, 2022: Three Months Ended Six Months Ended June 30, 2022 (As Restated) (1) (As Restated) (1) Net loss attributable to non-controlling interests $ (189,945) $ (290,878) Redeemable Non-controlling Interest Reconciliation — Mezzanine Equity Six Months Ended June 30, 2022 (Restated) (1) Beginning balance - December 31, 2021 $ 2,901,899 Preferred share Accretion adjustment as of June 30, 2022 322,932 Ending balance - June 30, 2022 $ 3,224,832 (1) See Note 2. Profits Interests Units (Class D Incentive Units) In April 2022, Levo issued Class D Incentive Units to certain key employees in the form of profits interests within the meaning of the Internal Revenue Service (“Profits Interests”). Any future distributions under the Profits Interests will only occur once distributions made to all other member units exceed a threshold amount. The Company performed an analysis of the key features of the Profits Interests to determine whether the nature of the Profits Interests are (a) an equity award which should be accounted for under ASC 718, Compensation – Stock Compensation or (b) a bonus arrangement which should be accounted for under ASC 710, Compensation – General . Based on the features of the Profits Interests, the awards are considered stock compensation to be accounted for as equity. Accordingly, compensation expense for the Profits Interests will be recognized over the vesting period of the awards. Subject to the grantee not incurring a termination prior to the applicable vesting date, the Incentive Units will vest as follows: (i) 80% of the Incentive Units will vest in equal 25.0% installments on each of the first four (4) anniversaries of the grant date (such that 80% of the total number of Incentive Units issued to the grantee hereunder will be vested on the fourth anniversary of the Grant Date) and (ii) the remaining 20% of the Incentive Units will vest upon a Change of Control. Therefore, the expenses recorded will only reflect the 80% vesting portion. During the six months ended June 30, 2022, the Company recorded compensation expense under the Profits Interests of $140,850 . The Company uses the M onte Carlo Simulation model to estimate the fair value of Class D Incentive Units. Fair value is estimated at the date of grant for employee and nonemployee options. The following assumptions were used in the M onte Carlo Simulation model to calculate the fair value of Class D Incentive Units granted for the six months ended June 30, 2022. Class D Units Expected life of Class D Incentive Units (in years) (1) 5.5 Risk-free interest rate (2) 3.02 % Volatility (3) 69.50 % __________________ (1) The expected life of options is the average of the contractual term of the Class D Incentive Units and the vesting period. (2) The risk-free interest rate is based on the yields on U.S. Treasury debt securities with maturities approximating the estimated life of the options. (3) Volatility is estimated by management. As the Company has been a private company for most of its existence, there is not enough historical volatility data related to the Company’s Common stock as a public entity. Therefore, this estimate is based on the average volatility of certain public company peers within the Company’s industry. A summary of the status of the Company’s Class D Incentive Units as of December 31, 2021, and changes during the six months ended June 30, 2022, is presented below: Shares Weighted- Nonvested at December 31, 2021 — — Granted 250,000 13.28 Vested — — Cancelled — — Nonvested and Outstanding at June 30, 2022 250,000 13.28 As of June 30, 2022, there was $2,698,822 of total unrecognized compensation cost related to nonvested Class D Incentive Units. The Company expects to recognize this compensation cost over a remaining weighted-average period of approximately 3.8 years.

Subsequent Events

Subsequent Events	6 Months Ended
Subsequent Events	Jun. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Warehouse Lease In July 2022, the Company entered into a lease agreement in Westland, Michigan for 10,000 square feet of warehouse space for the purpose of having its own controlled warehouse facility for its finished inventories. The term of the lease is 36 months with a fixed rent of $5,625 per month. There is an option to renew the lease for an additional 36 months, however it is not reasonably certain the Company will exercise the renewal. There is no option to purchase the premises at lease termination. The following is a maturity analysis of the annual undiscounted cash flows under new lease as of June 30, 2022 : 2022 $ 39,375 2023 67,500 2024 67,500 2025 28,125 Total lease payments $ 202,500 Securities Purchase Agreement, Pre-Funded Warrants and Warrants On July 27, 2022, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with a certain institutional and accredited investor (the “Purchaser”), relating to the issuance and sale of 2,150,000 shares (the “Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), pre-funded warrants to purchase an aggregate of 1,850,000 shares of Common Stock (the “Pre-Funded Warrants”), and warrants (the “Warrants”) to purchase an aggregate of 4,000,000 shares of Common Stock in a registered direct offering (the “Offering”). The offering closed on July 29, 2022. The offering price for the Shares, and accompanying Warrants, was $3.50 per Share and the offering price for the Pre-Funded Warrants, and accompanying was $3.4999 per Pre-Funded Warrant, which represents the per Share public offering price less $0.0001 per share exercise price for each Pre-Funded Warrant. Each Pre-Funded Warrant has an exercise price of $0.0001 per share of common stock, subject to adjustment for stock splits, reverse stock splits, stock dividends and similar transactions. The Warrants have an exercise price of $3.75 per share of common stock, subject to adjustment for stock splits, reverse stock splits, stock dividends and similar transactions, and each Warrant are exercisable for one share of Common Stock. The Warrants are exercisable beginning six months from the date of issuance and the Pre-Funded Warrants are be exercisable immediately upon issuance. The Pre-Funded Warrants terminate when fully exercised and the Warrants terminate five years from the initial exercisability date. The aggregate gross proceeds to the Company from the Offering were approximately $14.0 million and net proceeds were approximately $13.1 million , excluding the proceeds, if any, from the exercise of the Pre-Funded Warrants and the Warrants. The Company intends to use the net proceeds from the Offering for working capital and general corporate purposes. Craig-Hallum Capital Group LLC (the “Placement Agent”) was the exclusive placement agent for the Offering. The Offering was made pursuant to an effective registration statement on Form S-3 (Registration Statement No. 333-264462), as previously filed with and declared effective by the Securities and Exchange Commission (the “SEC”), a base prospectus included as part of the registration statement, and a final prospectus supplement filed with the SEC on July 28, 2022, pursuant to Rule 424(b) under the Securities Act of 1933, as amended. Placement Agency Agreement In connection with the Offering, the Company also entered into a placement agency agreement with the Placement Agent. Pursuant to the Placement Agency Agreement, the Company paid to the Placement Agent a fee equal to 6.0% of the gross proceeds received by the Company in the Offering in the form of cash.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
Summary of Significant Accounting Policies (Policies)	Jun. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited (i) condensed consolidated balance sheet as of December 31, 2021, which has been derived from audited financial statements, and (ii) the unaudited interim condensed financial statements have been prepared in accordance pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. Therefore, it is suggested that these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes in the 2021 Form 10-K, filed with the SEC on March 31, 2022. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the financial position, results of operations, comprehensive loss, cash flows, and stockholders’ equity for the interim periods, but are not necessarily indicative of the results to be anticipated for the full year 2022 or any future period. In accordance with Accounting Standards Codification ("ASC") 205-40, Presentation of Financial Statements - Going Concern, the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the that the consolidated financial statements are issued. Since inception, the Company has incurred recurring losses and negative cash flows from operations since inception and has an accumulated deficit of $102.8 million as of June 30, 2022. Nuvve incurred operating losses of approximately $19.6 million as of the six months ended June 30, 2022, and $27.2 million and $4.7 million for the years ended December 31, 2021, and 2020, respectively. As of June 30, 2022, Nuvve had a cash balance, working capital, and stockholders’ equity of $14.9 million, $23.4 million and $23.5 million, respectively. The Company continues to expect to generate operating losses and negative cash flows and may need additional funding to support its planned operating activities through profitability. The transition to profitability is dependent upon the successful expanded commercialization of the Company's Grid Integrated Vehicle ("GIVe") platform and the achievement of a level of revenues adequate to support its cost structure. On May 5, 2022, the Company entered into an at-the-market offering agreement in which the Company from time to time during the term of the sales agreement, offer and sell shares of its common stock having an aggregate offering price up to a total of $25.0 million in gross proceeds. Shares of common stock sold under the sales agreement are offered and sold pursuant to the Company's shelf registration statement. During the six months ended June 30, 2022, the Company sold 323,746 shares of common stock pursuant to the sales agreement at an average price of $6.12 per share for aggregate net proceeds of approximately $1.9 million. Additionally, during the month of July 2022, the Company sold 469,136 shares of common stock pursuant to the sales agreement at an average price of $4.17 per share for aggregate net proceeds of approximately $1.9 million. In July 2022, the Company had a direct equity offering of its common stock. See Note 19 for details. The aggregate gross proceeds to the Company from the offering were approximately $14.0 million and net proceeds were $13.1 million . The Company expects its cash and cash equivalents as of August 11, 2022 will be sufficient to fund current planned operations for at least the next twelve months from the date of issuance of these consolidated financial statements. Management's expectations with respect to its ability to fund current planned operations is based on estimates that are subject to risks and uncertainties. Actual results could be different from management's estimates and should actual results be less favorable than these estimates management would ultimately need to take corrective steps to improve future operating results and its financial condition.
Principles of Consolidation	Principles of ConsolidationThe condensed consolidated financial statements include the accounts and operations of the Company, its wholly owned subsidiaries and its consolidated variable interest entity. All intercompany accounts and transactions have been eliminated upon consolidation.
Variable Interest Entities	Variable Interest Entities Pursuant to the consolidation guidance, the Company first evaluates whether it holds a variable interest in an entity in which it has a financial relationship and, if so, whether or not that entity is a variable interest entity ("VIE"). A VIE is an entity with insufficient equity at risk for the entity to finance its activities without additional subordinated financial support or in which equity investors lack the characteristics of a controlling financial interest. If an entity is determined to be a VIE, the Company evaluates whether the Company is the primary beneficiary. The primary beneficiary analysis is a qualitative analysis based on power and economics. The Company concludes that it is the primary beneficiary and consolidates the VIE if the Company has both (i) the power to direct the activities of the VIE that most significantly influence the VIE's economic performance, and (ii) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. The Company formed Levo with Stonepeak and Evolve, in which the Company owns 51% of Levo's common units. The Company has determined that Levo is a VIE in which the Company is the primary beneficiary. Accordingly, the Company consolidates Levo and records a non-controlling interest for the share of the entity owned by Stonepeak and Evolve. Assets and Liabilities of Consolidated VIEs The Company's condensed consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders’ interests are reflected in "Net loss attributable to non-controlling interests" in the condensed consolidated statements of operations and "Non-controlling interests" in the condensed consolidated balance sheets. See Note 18 for details of non-controlling interests. The Company began consolidating the assets, liabilities and results of operations of Levo during the quarter ended September 30, 2021.
Noncontrolling Interest	Redeemable Non-Controlling Interest - Mezzanine Equity Redeemable non-controlling interest represents the shares of the preferred stock issued by Levo to Stonepeak and Evolve (the "preferred shareholders") who own 49% of Levo common units. The preferred stock is not mandatorily redeemable or currently redeemable, but it could be redeemable with the passage of time at the election of Levo, the preferred shareholders or a trigger event as defined in the preferred stock agreement. As a result of the contingent put right available to the preferred shareholders, the redeemable non-controlling interests in Levo are classified outside of permanent equity in the Company’s unaudited condensed consolidated balance sheets as mezzanine equity. The initial carrying value of the redeemable non-controlling interest is reported at the initial proceeds received on issuance date, reduced by the fair value of embedded derivatives resulting in an adjusted initial carrying value. The adjusted initial carrying value is further adjusted for the accretion of the difference with the redemption price value using the effective interest method. The accretion amount is a deemed dividend recorded against retained earnings or, in its absence, to additional-paid-in-capital. The carrying amount of the redeemable non-controlling interest is measured at the higher of the carrying amount adjusted each reporting period for income (or loss) attributable to the non-controlling interest, or the carrying amount adjusted each reporting period by the accretion amount. See Note 18 for details. Non-controlling interests For entities that are consolidated, but not 100% owned, a portion of the net income or loss and corresponding equity is allocated to owners other than the Company. The aggregate of the net income or loss and corresponding equity that is not owned by the Company is included in non-controlling interests in the condensed consolidated financial statements. Non-controlling interests are presented outside as a separate component of stockholders’ equity on the Company’s condensed consolidated Balance Sheets. The primary components of non-controlling interests are separately presented in the Company’s condensed consolidated statements of changes in stockholders’ equity to clearly distinguish the interest in the Company and other ownership interests in the consolidated entities. Net income or loss includes the net income or loss attributable to the holders of non-controlling interests on the Company’s condensed consolidated statements of operations. Net income or loss is allocated to non-controlling interests in proportion to their relative ownership interests.
Emerging Growth Company	Emerging Growth Company Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) permits emerging growth companies (“EGC”) to delay complying with new or revised financial accounting standards that do not yet apply to private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act). The Company qualifies as an EGC. The JOBS Act provides that an EGC can elect to opt-out of the extended transition period and comply with the requirements that apply to non-EGCs, but any such election to opt-out is irrevocable. The Company has elected not to opt-out of such an extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an EGC, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This different adoption timing may make a comparison of the Company’s financial statements with another public company, which is neither an EGC nor an EGC that has opted out of using the extended transition period, difficult or impossible because of the potential differences in accounting standards used.
COVID-19	COVID-19 The novel coronavirus (COVID-19) which was declared a pandemic in March 2020, and the related restrictive measures such as travel restrictions, quarantines, and shutdowns, has negatively impacted the global economy. As national and local governments in different countries ease COVID-19 restrictions, and vaccines are distributed and rolled out successfully, we continue to see improved economic trends. However, COVID-19 and actions taken to mitigate its spread have had and are expected to continue to have an adverse impact on the economies and financial markets of many countries, including the geographical area in which the Company operates. The Company continues to monitor the situation closely but, at this time, is unable to predict the cumulative impact, both in terms of severity and duration, that the coronavirus pandemic has and will have on its business, operating results, cash flows and financial condition, and it could be material if the current circumstances continue to exist for a prolonged period of time. In addition to any direct impact on Nuvve’s business, it is reasonably possible that the estimates made by management in preparing Nuvve’s financial statements have been, or will be, materially and adversely impacted in the near term as a result of the on-going COVID-19 conditions.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions made by management include the impairment of intangible assets, the net realizable value of inventory, the fair value of share-based payments, the fair value of notes payable conversion options, revenue recognition, the fair value of warrants, and the recognition and disclosure of contingent liabilities. Management evaluates its estimates on an ongoing basis. Actual results could materially vary from those estimates.
Cash and Restricted Cash	Cash and Restricted Cash The Company maintains cash balances that can, at times, exceed amounts insured by the Federal Deposit Insurance Corporation, which is up to $250,000. The Company has not experienced any losses in these accounts and believes it is not exposed to any significant credit risk in this area.
Concentrations of Credit Risk	Concentrations of Credit Risk At June 30, 2022 and December 31, 2021, the financial instruments which potentially expose the Company to concentration of credit risk consist of cash in financial institutions (in excess of federally insured limits) and trade receivables. The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, or whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable, as follows: For the three and six months ended June 30, 2022 three and two customers accounted for 54.9% and 58.8% of revenue, respectively. For the three and six months ended June 30, 2021 two and three customers in aggregate accounted for 48.6% and 56.4% of revenue, respectively. During the three and six months ended June 30, 2022, the Company's top five customers accounted for approximately 71.8% and 70.1%, respectively, o f the Company’s total revenue. During the three and six months ended June 30, 2021, the Company's top five customers accounted for approximately 68.3% and 71.0%, respectively, o f the Company’s total revenue. At June 30, 2022 , two customers in aggregate accounted f or 37.1% of accounts receivable. At December 31, 2021 , two customers in aggregate accounted for 32.2% of accounts receivable. Approximat ely 58.5% a nd 56.0% of the Company’s trade accounts receivable balance was with five customers at June 30, 2022 and December 31, 2021 , respectively. The Company estimates its maximum credit risk for accounts receivable at the amount recorded on the balance sheet. The trade accounts receivables are generally short-term and all probable bad debt losses have been appropriately considered in establishing the allowance for doubtful accounts.
Revenue Recognition	Revenue Recognition Bill-and-hold arrangements - The Company occasionally enter a bill and hold arrangements in which some customers request that billed products that are ready for delivery be held at our warehouse facility for them until shipment at a later date. In this instance, revenue is recognized when; 1) the risks of ownership, including title, have passed to the customer, 2) the product must be identified separately as belonging to the customer, 3) the product currently must be ready for physical transfer to the customer, and 4) the Company does not have the ability to use the product or to direct it to another customer.
Investments in Equity Securities Without Readily Determinable Fair Values	Investments in Equity Securities Without Readily Determinable Fair Values Investments in equity securities of nonpublic entities without readily determinable fair values are carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company reviews its equity securities without readily determinable fair values on a regular basis to determine if the investment is impaired. For purposes of this assessment, the Company considers the investee’s cash position, earnings and revenue outlook, liquidity, and management ownership, among other factors, in its review. If management’s assessment indicates that an impairment exists, the Company estimates the fair value of the equity investment and recognizes in current earnings an impairment loss that is equal to the difference between the fair value of the equity investment and its carrying amount. In June 2022, the Company invested $1.0 million in Switch EV Ltd ("Switch"), a nonpublic entity incorporated and registered in the United Kingdom for a future equity ownership. Since Switch is a nonpublic entity, there is no readily determinable fair value. As of June 30, 2022, the Company’s investment in Switch was accounted for as an investment in equity securities without a readily determinable fair value subject to impairment. The Company did not recognize an impairment loss on its investment during the quarter ended June 30, 2022.
Recently adopted accounting pronouncements	Recently adopted accounting pronouncements None.
Recently issued accounting pronouncements not yet adopted	Recently issued accounting pronouncements not yet adopted In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326) – Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 requires, among other things, the use of a new current expected credit loss ("CECL") model in determining the allowances for doubtful accounts with respect to accounts receivable, accrued straight-line rents receivable, and notes receivable. The CECL model requires that an entity estimate its lifetime expected credit loss with respect to these receivables and record allowances that, when deducted from the balance of the receivables, represent the net amounts expected to be collected. Entities will also be required to disclose information about how the entity developed the allowances, including changes in the factors that influenced its estimate of expected credit losses and the reasons for those changes. This update is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
Summary of Significant Accounting Policies (Tables)	Jun. 30, 2022
Accounting Policies [Abstract]
Schedule of Restatement of Previously Issued Financial Statements	The following tables summarize the effect of the aforementioned adjustments on the Company's Condensed Consolidated Balance Sheets as of June 30, 2022, and the Company's Condensed Consolidated Statements of Operations, and Condensed Consolidated Statements of Cash Flows for the three and six months ended June 30, 2022: Condensed Consolidated Balance Sheet June 30, 2022 June 30, 2022 As Previously Reported Adjustment As Restated Redeemable non-controlling interests, preferred shares, zero par value, 1,000,000 shares authorized, 3,138 shares issued and outstanding at June 30, 2022 and December 31, 2021; aggregate liquidation preference of $3,330,071 at June 30, 2022 $ 3,208,360 $ 16,472 $ 3,224,832 Additional paid-in capital $ 134,261,487 $ (4,801,897) $ 129,459,590 Accumulated deficit $ (107,629,843) $ 4,793,496 $ (102,836,347) Nuvve Stockholders’ Equity (Deficit) $ 26,707,078 $ (8,401) $ 26,698,677 Non-controlling interests $ (3,236,683) $ (8,071) $ (3,244,754) Total Stockholders’ Equity (Deficit) $ 23,470,395 $ (16,472) $ 23,453,923 Three Months Ended June 30, Three Months Ended June 30, Three Months Ended June 30, Three Months Ended June 30, 2022 2022 2021 2021 Condensed Consolidated Statements of Operations As Previously Reported Adjustment As Restated As Previously Reported Adjustment As Restated Financing costs $ (43,562,847) $ 43,562,847 $ — $ — $ (43,818,000) $ (43,818,000) Change in fair value of warrants liability $ 251,000 $ 4,334,000 $ 4,585,000 $ (351,602) $ (3,145,628) $ (3,497,230) Total other (expense) income, net $ (43,315,418) $ 47,896,847 $ 4,581,429 $ 154,058 $ (46,963,628) $ (46,809,570) Loss before taxes $ (53,354,948) $ 47,896,847 $ (5,458,101) $ (6,186,306) $ (46,963,628) $ (53,149,934) Net loss $ (53,354,948) $ 47,896,847 $ (5,458,101) $ (6,187,306) $ (46,963,628) $ (53,150,934) Less: Net loss attributable to non-controlling interests $ (2,110,903) $ 1,920,958 $ (189,945) $ — $ — $ — Net loss attributable to Nuvve Holding Corp. $ (51,244,045) $ 45,975,889 $ (5,268,156) $ (6,187,306) $ (46,963,628) $ (53,150,934) Net loss attributable to Nuvve common stockholders $ (51,470,807) $ 45,975,889 $ (5,494,918) $ (6,187,306) $ (46,963,628) $ (53,150,934) Net loss per share attributable to Nuvve common stockholders, basic and diluted $ (2.70) $ 2.41 $ (0.29) $ (0.33) $ (2.52) $ (2.85) Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, 2022 2022 2021 2021 Condensed Consolidated Statements of Operations As Previously Reported Adjustment As Restated As Previously Reported Adjustment As Restated Financing costs $ (43,562,847) $ 43,562,847 $ — $ — $ (43,818,000) $ (43,818,000) Change in fair value of warrants liability $ 684,000 $ 8,677,000 $ 9,361,000 $ 70,228 $ (3,145,628) $ (3,075,400) Total other (expense) income, net $ (42,857,275) $ 52,239,847 $ 9,382,572 $ (133,776) $ (46,963,628) $ (47,097,404) Loss before taxes $ (62,429,209) $ 52,239,847 $ (10,189,362) $ (11,548,026) $ (46,963,628) $ (58,511,654) Net loss $ (62,429,209) $ 52,239,847 $ (10,189,362) $ (11,549,026) $ (46,963,628) $ (58,512,654) Less: Net loss attributable to non-controlling interests $ (2,211,837) $ 1,920,959 $ (290,878) $ — $ — $ — Net loss attributable to Nuvve Holding Corp. $ (60,217,372) $ 50,318,888 $ (9,898,484) $ (11,549,026) $ (46,963,628) $ (58,512,654) Net loss attributable to Nuvve common stockholders $ (60,669,615) $ 50,318,888 $ (10,350,727) $ (11,549,026) $ (46,963,628) $ (58,512,654) Net loss per share attributable to Nuvve common stockholders, basic and diluted $ (3.20) $ 2.65 $ (0.55) $ (0.79) $ (3.23) $ (4.02) Three Months Ended June 30, Three Months Ended June 30, Three Months Ended June 30, Three Months Ended June 30, 2022 2022 2021 2021 CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS As Previously Reported Adjustment As Restated As Previously Reported Adjustment As Restated Net loss $ (53,354,948) 47,896,847 $ (5,458,101) $ (6,187,306) (46,963,628) $ (53,150,934) Less: Comprehensive loss attributable to non-controlling interests $ (2,110,903) 1,920,958 $ (189,945) $ — — — Comprehensive loss attributable to Nuvve common stockholders $ (51,043,497) 45,975,789 $ (5,067,708) $ (6,207,452) (46,963,628) $ (53,171,080) Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, 2022 2022 2021 2021 CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS As Previously Reported Adjustment As Restated As Previously Reported Adjustment As Restated Net loss $ (62,429,209) 52,239,847 $ (10,189,362) $ (11,549,026) (46,963,628) $ (58,512,654) Less: Comprehensive loss attributable to non-controlling interests $ (2,211,837) 1,920,959 $ (290,878) $ — — $ — Comprehensive loss attributable to Nuvve common stockholders $ (59,805,127) 50,318,888 $ (9,486,239) $ (11,452,423) (46,963,628) $ (58,416,051) CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY As Previously Reported Adjustment As Restated Issuance of warranties to Stonepeak and Evolve $ 30,234,000 $ (7,977,372) $ 22,256,628 Net Loss $ (6,187,306) $ (46,963,628) $ (53,150,934) Balance June 30, 2021 $ 94,830,025 $ (54,941,000) $ 39,889,025 Net Loss $ (9,074,261) $ 4,343,000 $ (4,731,261) Balance March 31, 2022 $ 71,410,982 $ (47,913,319) $ 23,497,663 Net Loss $ (53,354,948) $ 47,896,847 $ (5,458,101) Balance June 30, 2022 $ 23,470,395 $ (16,472) $ 23,453,923 Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, 2022 2022 2021 2021 Condensed Consolidated Statements of Cash Flows As Previously Reported Adjustment As Restated As Previously Reported Adjustment As Restated Operating activities Net loss $ (62,429,209) $ 52,239,847 $ (10,189,362) $ (11,549,026) $ (46,963,628) $ (58,512,654) Adjustments to reconcile to net loss to net cash used in operating activities Financing costs $ 43,562,847 $ (43,562,847) $ — $ — $ 43,818,000 $ 43,818,000 Change in fair value of warrants liability $ (684,000) $ (8,677,000) $ (9,361,000) $ (70,228) $ 3,145,628 $ 3,075,400 Net cash used in operating activities $ (20,021,165) $ — $ (20,021,165) $ (13,413,426) $ — $ (13,413,426)
Schedule of assets and liabilities included in the company’s condensed consolidated balance sheets	The following table summarizes the carrying amounts of Levo assets and liabilities included in the Company’s condensed consolidated balance sheets at June 30, 2022: June 30, 2022 Assets Cash $ 28,068 Total Assets $ 28,068 Liabilities and Mezzanine Equity Accrued expenses $ 212,071 Derivative liability - non-controlling redeemable preferred shares 491,012 Total Liabilities $ 703,083

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
Revenue Recognition (Tables)	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
Schedule of information regarding disaggregated revenue based on revenue by service	The following table provides information regarding disaggregated revenue based on revenue by service lines for the three and six months ended June 30: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Revenue recognized over time: Services $ 73,522 $ 363,366 $ 268,172 $ 530,611 Grants 233,698 214,814 350,947 701,943 Products 994,507 403,150 3,053,641 547,808 Total revenue $ 1,301,727 $ 981,330 $ 3,672,760 $ 1,780,362
Schedule of aggregate amount of revenue for the Company’s existing contracts with customers	The aggregate amount of revenue for the Company’s existing contracts and grants with customers as of June 30, 2022 expected to be recognized in the future, and classified as deferred revenue on the condensed consolidated Balance Sheet, for years ended December 31, is as follows (this disclosure does not include revenue related to contracts whose original expected duration is one year or less): 2022 (remaining six months) $ 138,399 Thereafter 643,523 Total $ 781,922
Schedule of company operates in a single business segment	The following table summarizes the Company’s revenues for the three and six months ended June 30, 2022 and 2021: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Revenues: United States $ 1,125,586 $ 812,796 $ 3,353,976 $ 1,404,627 United Kingdom 99,995 113,703 137,385 254,989 Denmark 76,146 54,831 181,399 120,746 $ 1,301,727 $ 981,330 $ 3,672,760 $ 1,780,362 The following table summarizes the Company’s long-lived assets in different geographic locations as of June 30, 2022 and December 31, 2021: June 30, December 31, Long-lived assets: United States $ 1,915,685 $ 1,811,607 Denmark 20,827 25,664 $ 1,936,512 $ 1,837,271

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
Fair Value Measurements (Tables)	Jun. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of liabilities measured at fair value on the condensed consolidated balance sheet	The following are the liabilities measured at fair value on the condensed consolidated balance sheet at June 30, 2022 using quoted price in active markets for identical assets (Level 1); significant other observable inputs (Level 2); and significant unobservable inputs (Level 3): Level 1: Level 2: Level 3: Total at June 30, Total Gains (Losses) For The Three Months Ended June 30, 2022 Total Gains (Losses) For The Six Months Ended June 30, 2022 Recurring fair value measurements Private warrants $ — $ — $ 182,000 $ 182,000 $ 251,000 $ 684,000 Stonepeak and Evolve unvested warrants $ — $ — $ — $ — $ 4,334,000 $ 8,677,000 Derivative liability - non-controlling redeemable preferred shares $ — $ — $ 491,012 $ 491,012 $ (32,536) $ 20,936 Total recurring fair value measurements $ — $ — $ 673,012 $ 673,012 $ 4,552,464 $ 9,381,936 Level 1: Level 2: Level 3: Total at June 30, Total Gains (Losses) For The Three Months Ended June 30, 2021 Total Gains (Losses) For The Six Months Ended June 30, 2021 Recurring fair value measurements Private warrants $ — $ — $ 1,183,000 $ 1,183,000 $ (351,602) $ 70,228 Stonepeak and Evolve unvested warrants (As Restated) (1) $ — $ — $ 11,123,000 $ 11,123,000 $ (3,145,628) $ (3,145,628) Total recurring fair value measurements $ — $ — $ 12,306,000 $ 12,306,000 $ (3,497,230) $ (3,075,400)
Schedule of fair value on a recurring basis	The following is a reconciliation of the opening and closing balances for the liabilities related to the warrants (Note 11) and derivative liability - non-controlling redeemable preferred shares measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three and six months ended June 30, 2022: Private Warrants Stonepeak and Evolve unvested warrants Non-controlling redeemable preferred shares - derivative liability (As Restated) (1) Balance at December 31, 2021 $ 866,000 $ 8,677,000 $ 511,948 Total (gains) losses for period included in earnings (433,000) (4,343,000) (53,472) Balance at March 31, 2022 433,000 4,334,000 458,476 Total (gains) losses for period included in earnings (251,000) (4,334,000) 32,536 Balance at June 30, 2022 $ 182,000 $ — $ 491,012
Fair Value Measurement Inputs and Valuation Techniques	The following table presents the significant unobservable inputs and valuation methodologies used for the Company’s fair value measurements of non-recurring (level 3) Stonepeak and Evolve unvested warrants at June 30, 2022 : Series C Unvested Warrants Series D Unvested Warrants Series E Unvested Warrants Series F Unvested Warrants Fair value (in millions) $— $— $— $— Valuation methodology Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Term (years) 8.90 8.90 8.90 8.90 Risk free rate 3.0% 3.0% 3.0% 3.0% Exercise price $15.0 $20.0 $30.0 $40.0 Volatility 56.0% 56.0% 56.0% 56.0% Capital expenditure forecast (in millions) $125.0 $250.0 $375.0 $500.0 Probability of warrants vesting (a) —% —% —% —% __________________ (a) During the second quarter ended June 30, 2022, the Company significantly lowered its forecast of Levo's capital deployments due to the passage by the United States Congress of the Infrastructure Investment and Jobs Act bill, and the related unveiling of the Environmental Protection Agency’s 2022 Clean School Bus rebates. The resulting lower forecast of capital deployments reduced the probabilities of the future vesting of the unvested warrants. The following table presents the significant unobservable inputs and valuation methodologies used for the Company’s fair value measurements of non-recurring (level 3) Stonepeak and Evolve unvested warrants at June 30, 2021: Series C Unvested Warrants Series D Unvested Warrants Series E Unvested Warrants Series F Unvested Warrants Fair value (in millions) $3.8 $3.1 $2.4 $1.9 Valuation methodology Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Monte Carlo Simulation & Black Scholes Term (years) 9.90 9.90 9.90 9.90 Risk free rate 1.4% 1.4% 1.4% 1.4% Exercise price $15.0 $20.0 $30.0 $40.0 Volatility 55.0% 55.0% 55.0% 55.0% Capital expenditure forecast (in millions) $125.0 $250.0 $375.0 $500.0 Probability of warrants vesting 97.1% 88.2% 78.8% 70.4%

Derivative Liability - Non-Co_2

Derivative Liability - Non-Controlling Redeemable Preferred Stock (Tables)	6 Months Ended
	Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Liabilities at Fair Value	The following table display the fair value of derivatives by balance sheet line item at June 30, 2022 and December 31, 2021: June 30, 2022 December 31, 2021 Other long term liabilities: Derivative liability - non-controlling redeemable preferred shares $ 491,012 $ 511,948

Account Receivables, Net (Table

Account Receivables, Net (Tables)	6 Months Ended
Account Receivables, Net (Tables)	Jun. 30, 2022
Receivables [Abstract]
Schedule of accounts receivable	The following tables summarizes the Company's accounts receivable on the consolidated balance sheets at June 30, 2022 and December 31, 2021: June 30, 2022 December 31, 2021 Trade receivables $ 2,021,844 $ 1,949,896 Less: allowance for doubtful accounts (63,188) (63,188) Accounts receivable, net $ 1,958,656 $ 1,886,708 Allowance for doubtful accounts: Balance December 31, 2021 $ (63,188) Provision — Write-off — Recoveries — Balance June 30, 2022 $ (63,188)

Inventories (Tables)

Inventories (Tables)	6 Months Ended
Inventories (Tables)	Jun. 30, 2022
Inventory Disclosure [Abstract]
Schedule of inventory by category	The following table summarizes the Company’s inventories balance by category: June 30, 2022 December 31, 2021 DC Chargers $ 8,852,624 $ 7,687,598 AC Chargers 214,486 232,920 Vehicles - School Buses (1) 1,620,000 3,180,000 Others 108,922 17,670 Total $ 10,796,032 $ 11,118,188 __________________ (1) As of June 30, 2022, the Company has taken delivery of ten school buses it has committed to purchase from the manufacturer within one year from the purchase order date of May 26, 2021. Five school buses were sold during first quarter ended March 31, 2022.

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	6 Months Ended
Property, Plant and Equipment (Tables)	Jun. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	The following table summarizes the Company’s property, plant and equipment balance at June 30, 2022 and December 31, 2021: June 30, 2022 December 31, 2021 Computers & Servers $ 126,931 $ 105,499 Vehicles 168,862 168,862 Office furniture and equipment 332,007 161,771 Others 131,607 6,050 Total 759,407 442,182 Less: Accumulated Depreciation (158,861) (85,988) Property, plant and equipment, net $ 600,546 $ 356,194 June 30, 2022 June 30, 2021 Depreciation expense $ 62,265 $ 12,147

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
Intangible Assets (Tables)	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of estimated future amortization expense amortizable intangible assets	Total estimated future amortization expense is as follows: 2022 (remaining six months) $ 69,719 2023 139,437 2024 139,437 2025 139,437 2026 139,437 Thereafter 783,891 $ 1,411,358

Stockholders_ Equity (Tables)

Stockholders’ Equity (Tables)	6 Months Ended
Stockholders’ Equity (Tables)	Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Schedule of common stock issuable upon exercise of warrants outstanding	The following table is a summary of the number of shares of the Company’s Common Stock issuable upon exercise of warrants outstanding at June 30, 2022 (there were no warrants outstanding at December 31, 2021): Number of Number of Exercise Expiration Public Warrants 2,875,000 2,875,000 $11.50 March 19, 2026 Private Warrants 136,250 136,250 $11.50 March 19, 2026 PIPE Warrants 1,353,750 1,353,750 $11.50 March 19, 2026 Stonepeak/Evolve Warrants - series B 2,000,000 2,000,000 $10.00 May 17, 2031 Stonepeak/Evolve Warrants - series C 1,000,000 500,000 $15.00 May 17, 2031 Stonepeak/Evolve Warrants - series D 1,000,000 500,000 $20.00 May 17, 2031 Stonepeak/Evolve Warrants - series E 1,000,000 500,000 $30.00 May 17, 2031 Stonepeak/Evolve Warrants - series F 1,000,000 500,000 $40.00 May 17, 2031 10,365,000 8,365,000

Stock Option Plan (Tables)

Stock Option Plan (Tables)	6 Months Ended
Stock Option Plan (Tables)	Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of stock-based compensation expense for stock options	Stock-based compensation expense for the three and six months ended June 30 are as follows Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Options $ 548,652 $ 810,738 $ 1,370,758 $ 1,063,008 Restricted stock 1,187,254 258,137 1,801,093 267,972 Total $ 1,735,906 $ 1,068,875 $ 3,171,851 $ 1,330,980
Schedule of black-scholes option pricing model to estimate the fair value of stock options	The following assumptions were used in the Black-Scholes model to calculate the fair value of stock options granted for the six months ended June 30, 2022 for the 2010 Plan and the 2020 Plan. 2010 Plan 2020 Plan Expected life of options (in years) (1) 6.1 6.1 Dividend yield (2) 0 % 0 % Risk-free interest rate (3) 2.00 % 2.00 % Volatility (4) 54.1 % 54.1 % __________________ (1) The expected life of options is the average of the contractual term of the options and the vesting period. (2) No cash dividends have been declared on the Company’s common stock since the Company’s inception, and the Company currently does not anticipate declaring or paying cash dividends over the expected life of the options. (3) The risk-free interest rate is based on the yields on U.S. Treasury debt securities with maturities approximating the estimated life of the options. (4) Volatility is estimated by management. As the Company has been a private company for most of its existence, there is not enough historical volatility data related to the Company’s Common stock as a public entity. Therefore, this estimate is based on the average volatility of certain public company peers within the Company’s industry. onte Carlo Simulation model to calculate the fair value of Class D Incentive Units granted for the six months ended June 30, 2022. Class D Units Expected life of Class D Incentive Units (in years) (1) 5.5 Risk-free interest rate (2) 3.02 % Volatility (3) 69.50 % __________________ (1) The expected life of options is the average of the contractual term of the Class D Incentive Units and the vesting period. (2) The risk-free interest rate is based on the yields on U.S. Treasury debt securities with maturities approximating the estimated life of the options. (3) Volatility is estimated by management. As the Company has been a private company for most of its existence, there is not enough historical volatility data related to the Company’s Common stock as a public entity. Therefore, this estimate is based on the average volatility of certain public company peers within the Company’s industry.
Schedule of stock option activity	The following is a summary of the stock option activity under the 2010 Plan, as converted to the Company’s shares due to Reverse Recapitalization, for the six months ended June 30, 2022: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2021 1,035,035 3.21 5.90 5,688,201 Granted — — — — Exercised (42,729) 2.42 — — Forfeited (36,065) 7.61 — — Expired/Cancelled (5,310) 1.37 — — Outstanding - June 30, 2022 950,931 3.09 5.24 2,264,735 Options Exercisable at June 30, 2022 836,687 2.52 4.84 2,257,456 Option Vested at June 30, 2022 836,687 2.52 4.84 2,257,456 The following is a summary of the stock option activity under the 2020 Plan for the six months ended June 30, 2022: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2021 1,602,850 13.18 9.27 46,920 Granted 121,100 6.87 9.86 — Exercised — — — — Forfeited (128,450) 10.18 — — Expired/Cancelled (1,250) 8.25 — — Outstanding - June 30, 2022 1,594,250 12.84 8.83 — Options Exercisable at June 30, 2022 422,327 13.38 8.74 — Option Vested at June 30, 2022 422,327 13.38 8.74 — A summary of the status of the Company’s Class D Incentive Units as of December 31, 2021, and changes during the six months ended June 30, 2022, is presented below: Shares Weighted- Nonvested at December 31, 2021 — — Granted 250,000 13.28 Vested — — Cancelled — — Nonvested and Outstanding at June 30, 2022 250,000 13.28
Disclosure of share-based compensation arrangements by share-based payment award	Other Information: Six Months Ended 2022 2021 Amount received from option exercised $ 173,575 $ — June 30, 2022 Weighted average remaining recognition period Total unrecognized options compensation costs $ 7,767,742 2.80
Schedule of nonvested restricted stock units	A summary of the status of the Company’s nonvested restricted stock units as of December 31, 2021, and changes during the six months ended June 30, 2022, is presented below: Shares Weighted- Nonvested at December 31, 2021 353,817 11.00 Granted 134,575 6.16 Vested/Release (202,141) 11.15 Cancelled/Forfeited (6,294) 9.93 Nonvested and Outstanding at June 30, 2022 279,957 8.60

Income Taxes (Tables)

Income Taxes (Tables)	6 Months Ended
Income Taxes (Tables)	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Schedule of income tax information	Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Income tax (benefit) expense $ — $ 1,000 $ — $ 1,000 Effective tax rate 0.0 % 0.0 % 0.0 % 0.0 %

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	6 Months Ended
	Jun. 30, 2022
Earnings Per Share [Abstract]
Schedule of earnings per share	The following table sets forth the calculation of basic and diluted net loss per share attributable to common stockholders during the three and six months ended June 30, 2022 and 2021: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Net loss attributable to Nuvve common stockholders $ (5,494,918) $ (53,150,934) $ (10,350,727) $ (58,512,654) Weighted-average shares used to compute net loss per share attributable to Nuvve common stockholders, basic and diluted 19,064,854 18,668,009 18,965,167 14,560,862 Net Loss per share attributable to Nuvve common stockholders, basic and diluted $ (0.29) $ (2.85) $ (0.55) $ (4.02)
Schedule of antidilutive securities excluded from the computation of earnings per share	The following outstanding shares of common stock equivalents were excluded from the calculation of the diluted net loss per share attributable to Nuvve common stockholders because their effect would have been anti-dilutive: Three Months Ended June 30, Six Months Ended June 30, 2022 2021 2022 2021 Stock options issued and outstanding 2,688,173 2,505,711 2,858,756 1,792,556 Nonvested restricted stock issued and outstanding 869,945 677,543 867,793 582,148 Public warrants 2,875,000 2,875,000 2,875,000 1,627,060 Private warrants 136,250 136,250 136,250 77,109 PIPE warrants 1,353,750 1,353,750 1,353,750 766,133 Stonepeak and Evolve warrants 6,000,000 2,901,099 6,000,000 1,450,549 Stonepeak and Evolve options 5,000,000 2,417,582 5,000,000 1,208,791 Total 18,923,118 12,866,935 19,091,549 7,504,346

Leases (Tables)

Leases (Tables)	6 Months Ended
Leases (Tables)	Jun. 30, 2022
Leases [Abstract]
Schedule of Lease costs	Supplemental unaudited consolidated balance sheet information related to leases is as follows: Classification June 30, 2022 Operating lease assets Right-of-use operating lease assets $ 5,195,474 Finance lease assets Property, plant and equipment, net 20,827 Total lease assets $ 5,216,301 Operating lease liabilities - current Operating lease liabilities - current $ 455,064 Operating lease liabilities - noncurrent Operating lease liabilities - noncurrent 5,053,219 Finance lease liabilities - current Other liabilities - current 7,022 Finance lease liabilities - noncurrent Other long-term liabilities 15,120 Total lease liabilities $ 5,530,425 The components of lease expense are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2022 2021 2022 2021 Operating lease expense Selling, general and administrative $ 164,076 $ 33,396 $ 340,597 $ 91,827 Finance lease expense: Amortization of finance lease assets Selling, general and administrative 1,451 2,190 7,391 2,190 Interest on finance lease liabilities Interest expense 599 510 1,238 510 Total lease expense $ 166,126 $ 36,096 $ 349,226 $ 94,527 Lease term and discount rate: June 30, 2022 Weighted-average remaining lease terms (in years): Operating lease 9.5 Finance lease 3.8 Weighted-average discount rate: Operating lease 7.8% Finance lease 7.8% Other Information: Six Months Ended June 30, Six Months Ended June 30, 2022 2021 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 80,869 $ 94,818 Operating cash flows from finance leases $ 1,238 $ 510 Financing cash flows from finance leases $ 4,425 $ 1,989 Leased assets obtained in exchange for new finance lease liabilities $ 20,827 $ 29,977 Leased assets obtained in exchange for new operating lease liabilities $ — $ —
Schedule of Lessee, operating lease, liability, maturity	Operating Lease Finance Lease Maturities of lease liabilities are as follows: June 30, 2022 June 30, 2022 2022 $ 127,621 $ 3,511 2023 792,918 7,022 2024 824,712 7,022 2025 822,352 7,022 2026 847,022 — Thereafter 4,631,866 1,755 Total lease payments 8,046,491 26,332 Less: interest (2,538,208) (4,190) Total lease obligations $ 5,508,283 $ 22,142 The following is a maturity analysis of the annual undiscounted cash flows under new lease as of June 30, 2022 : 2022 $ 39,375 2023 67,500 2024 67,500 2025 28,125 Total lease payments $ 202,500
Schedule of Finance lease, liability, maturity	Operating Lease Finance Lease Maturities of lease liabilities are as follows: June 30, 2022 June 30, 2022 2022 $ 127,621 $ 3,511 2023 792,918 7,022 2024 824,712 7,022 2025 822,352 7,022 2026 847,022 — Thereafter 4,631,866 1,755 Total lease payments 8,046,491 26,332 Less: interest (2,538,208) (4,190) Total lease obligations $ 5,508,283 $ 22,142
Schedule of Sublease Income	Sublease income are as follows: Three Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, Six Months Ended June 30, Classification 2022 2021 2022 2021 Sublease lease income Other, net $ 20,125 $ — $ 20,125 $ —

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
Commitments and Contingencies (Tables)	Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of milestone event	Under the terms of the agreement, the Company will pay up to an aggregate $7,500,000 in royalties to the Seller upon achievement of milestones, related to the aggregate number of vehicles that have had access to the Company’s GIVe platform system for a period of at least six consecutive months, and for which the Company has received monetary consideration for such access pursuant to a subscription or other similar agreement with the vehicle’s owner as follows: Milestone Event: Aggregated Vehicles Milestone 10,000 $ 500,000 20,000 750,000 40,000 750,000 60,000 750,000 80,000 750,000 100,000 1,000,000 200,000 1,000,000 250,000 2,000,000 $ 7,500,000

Non-Controlling Interest (Table

Non-Controlling Interest (Tables)	6 Months Ended
Non-Controlling Interest (Tables)	Jun. 30, 2022
Noncontrolling Interest [Abstract]
Schedule of preferred stock	At June 30, 2022, Series B Preferred Stock consisted of the following: Shares Authorized Shares Issued and Outstanding Stated Value per Share Initial Carrying Value Accrued Preferred Dividends Liquidation Preference 1,000,000 3,138 $ 1,000 $ 3,138,000 $ 192,071 $ 3,330,071
Schedule of condensed financial statements	The following table summarizes Levo non-controlling interests presented as a separate component of stockholders’ equity on the Company’s condensed consolidated balance sheets at June 30, 2022: June 30, 2022 (As Restated) (1) Add: net loss attributable to non-controlling interests as of June 30, 2022 $ (290,878) Less: dividends paid to non-controlling interests as of June 30, 2022 129,311 Less: Preferred share accretion adjustment as of June 30, 2022 322,932 Non-controlling interests $ (743,121)
Schedule of condensed income statement	The following table summarizes Levo non-controlling interests presented as a separate component of the Company’s condensed consolidated statements of operations as of June 30, 2022: Three Months Ended Six Months Ended June 30, 2022 (As Restated) (1) (As Restated) (1) Net loss attributable to non-controlling interests $ (189,945) $ (290,878)
Schedule of redeemable noncontrolling interest	Redeemable Non-controlling Interest Reconciliation — Mezzanine Equity Six Months Ended June 30, 2022 (Restated) (1) Beginning balance - December 31, 2021 $ 2,901,899 Preferred share Accretion adjustment as of June 30, 2022 322,932 Ending balance - June 30, 2022 $ 3,224,832 (1) See Note 2.
Schedule of black-scholes option pricing model to estimate the fair value of stock options	The following assumptions were used in the Black-Scholes model to calculate the fair value of stock options granted for the six months ended June 30, 2022 for the 2010 Plan and the 2020 Plan. 2010 Plan 2020 Plan Expected life of options (in years) (1) 6.1 6.1 Dividend yield (2) 0 % 0 % Risk-free interest rate (3) 2.00 % 2.00 % Volatility (4) 54.1 % 54.1 % __________________ (1) The expected life of options is the average of the contractual term of the options and the vesting period. (2) No cash dividends have been declared on the Company’s common stock since the Company’s inception, and the Company currently does not anticipate declaring or paying cash dividends over the expected life of the options. (3) The risk-free interest rate is based on the yields on U.S. Treasury debt securities with maturities approximating the estimated life of the options. (4) Volatility is estimated by management. As the Company has been a private company for most of its existence, there is not enough historical volatility data related to the Company’s Common stock as a public entity. Therefore, this estimate is based on the average volatility of certain public company peers within the Company’s industry. onte Carlo Simulation model to calculate the fair value of Class D Incentive Units granted for the six months ended June 30, 2022. Class D Units Expected life of Class D Incentive Units (in years) (1) 5.5 Risk-free interest rate (2) 3.02 % Volatility (3) 69.50 % __________________ (1) The expected life of options is the average of the contractual term of the Class D Incentive Units and the vesting period. (2) The risk-free interest rate is based on the yields on U.S. Treasury debt securities with maturities approximating the estimated life of the options. (3) Volatility is estimated by management. As the Company has been a private company for most of its existence, there is not enough historical volatility data related to the Company’s Common stock as a public entity. Therefore, this estimate is based on the average volatility of certain public company peers within the Company’s industry.
Schedule of stock option activity	The following is a summary of the stock option activity under the 2010 Plan, as converted to the Company’s shares due to Reverse Recapitalization, for the six months ended June 30, 2022: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2021 1,035,035 3.21 5.90 5,688,201 Granted — — — — Exercised (42,729) 2.42 — — Forfeited (36,065) 7.61 — — Expired/Cancelled (5,310) 1.37 — — Outstanding - June 30, 2022 950,931 3.09 5.24 2,264,735 Options Exercisable at June 30, 2022 836,687 2.52 4.84 2,257,456 Option Vested at June 30, 2022 836,687 2.52 4.84 2,257,456 The following is a summary of the stock option activity under the 2020 Plan for the six months ended June 30, 2022: Shares Weighted- Weighted- Aggregate Intrinsic Value($) Outstanding - December 31, 2021 1,602,850 13.18 9.27 46,920 Granted 121,100 6.87 9.86 — Exercised — — — — Forfeited (128,450) 10.18 — — Expired/Cancelled (1,250) 8.25 — — Outstanding - June 30, 2022 1,594,250 12.84 8.83 — Options Exercisable at June 30, 2022 422,327 13.38 8.74 — Option Vested at June 30, 2022 422,327 13.38 8.74 — A summary of the status of the Company’s Class D Incentive Units as of December 31, 2021, and changes during the six months ended June 30, 2022, is presented below: Shares Weighted- Nonvested at December 31, 2021 — — Granted 250,000 13.28 Vested — — Cancelled — — Nonvested and Outstanding at June 30, 2022 250,000 13.28

Subsequent Events (Tables)

Subsequent Events (Tables)	6 Months Ended
Subsequent Events (Tables)	Jun. 30, 2022
Subsequent Events [Abstract]
Schedule of Lessee, operating lease, liability, maturity	Operating Lease Finance Lease Maturities of lease liabilities are as follows: June 30, 2022 June 30, 2022 2022 $ 127,621 $ 3,511 2023 792,918 7,022 2024 824,712 7,022 2025 822,352 7,022 2026 847,022 — Thereafter 4,631,866 1,755 Total lease payments 8,046,491 26,332 Less: interest (2,538,208) (4,190) Total lease obligations $ 5,508,283 $ 22,142 The following is a maturity analysis of the annual undiscounted cash flows under new lease as of June 30, 2022 : 2022 $ 39,375 2023 67,500 2024 67,500 2025 28,125 Total lease payments $ 202,500

Organization and Description _2

Organization and Description of Business (Details)	1 Months Ended
Organization and Description of Business (Details)	Mar. 31, 2020 employee	Jun. 30, 2022 subsidiary
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Number of employees who resigned \| employee	2
Nuvve
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Number of wholly owned subsidiaries		2
Nuvve Corp.
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Number of wholly owned subsidiaries		3

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)				1 Months Ended	3 Months Ended							6 Months Ended				12 Months Ended
		Jul. 27, 2022	May 05, 2022	Jul. 31, 2022	Jun. 30, 2022		Mar. 31, 2022	[3]	Jun. 30, 2021		Mar. 31, 2021	Jun. 30, 2022		Jun. 30, 2021		Dec. 31, 2021		Dec. 31, 2020	May 17, 2021
Summary of Significant Accounting Policies [Line Items]
Accumulated deficit	[1]				$ (102,836,347)							$ (102,836,347)				$ (92,937,863)
Operating loss	[2]				(10,039,530)				$ (6,340,364)			(19,571,934)		$ (11,414,250)
Net loss					(5,458,101)	[2],[3]	$ (4,731,261)		(53,150,934)	[2]	$ (5,361,720)	(10,189,362)	[2]	(58,512,654)	[4]	27,200,000		$ 4,700,000
Cash	[1]				14,890,242							14,890,242				32,360,520
Working capital					23,400,000							23,400,000
Stockholders' equity					23,453,923	[1],[3]	$ 23,497,663		39,889,025		$ 57,394,610	23,453,923	[1],[3]	39,889,025		$ 27,012,445	[1],[3]	$ (880,710)
Sale price (in Dollars per share)																			$ 50
Proceeds from common stock offering, net of offering costs												1,859,685		0
FDIC amount					250,000							250,000
Financing costs	[2]				0				$ 43,818,000			0		$ 43,818,000
Switch EV
Summary of Significant Accounting Policies [Line Items]
Equity method investments					$ 1,000,000							$ 1,000,000
Levo Mobility LLC \| Stonepeak
Summary of Significant Accounting Policies [Line Items]
Stonepeak and Evolve 49% ownership					49%							49%
Levo Mobility LLC \| Variable Interest Entity
Summary of Significant Accounting Policies [Line Items]
Cash					$ 28,068							$ 28,068
Variable interest entity												51%
Subsequent Event
Summary of Significant Accounting Policies [Line Items]
Gross proceeds from offering		$ 14,000,000
Net proceeds from offering		$ 13,100,000
At The Market Offering
Summary of Significant Accounting Policies [Line Items]
Gross proceeds from offering			$ 25,000,000
Sale of units (in Shares)												323,746
Sale price (in Dollars per share)					$ 6.12							$ 6.12
Proceeds from common stock offering, net of offering costs												$ 1,900,000
At The Market Offering \| Subsequent Event
Summary of Significant Accounting Policies [Line Items]
Sale of units (in Shares)				469,136
Sale price (in Dollars per share)				$ 4.17
Proceeds from common stock offering, net of offering costs				$ 1,900,000

[1]Note 2.[2]Note 2.[3]See Note 2.[4]Note 2.

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Restatement of Previously Issued Financial Statements - Condensed Consolidated Balance Sheets (Details) - USD ($)		Jun. 30, 2022		Mar. 31, 2022		Dec. 31, 2021		Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020
Mezzanine equity
Redeemable non-controlling interests, preferred shares, zero par value, 1,000,000 shares authorized, 3,138 shares issued and outstanding at June 30, 2022 and December 31, 2021; aggregate liquidation preference of $3,330,071 at June 30, 2022		$ 3,224,832
Stockholders’ (Deficit) Equity
Additional paid-in capital	[1]	129,459,590				$ 122,336,607
Accumulated deficit	[1]	(102,836,347)				(92,937,863)
Nuvve Holding Corp. Stockholders’ Equity (Deficit)	[1]	26,698,677				29,514,078
Non-controlling interests	[1]	(3,244,754)				(2,501,633)
Total Stockholders’ Equity (Deficit)		$ 23,453,923	[1],[2]	$ 23,497,663	[2]	$ 27,012,445	[1],[2]	$ 39,889,025	$ 57,394,610	$ (880,710)
Temporary equity, par value (in Dollars per share)		$ 0				$ 0
Temporary equity, shares authorized (in Shares)		1,000,000				1,000,000
Temporary equity, shares outstanding (in Shares)		3,138				3,138
Temporary equity, shares issued (in Shares)		3,138				3,138
Temporary equity, liquidation preference		$ 3,330,071
As Previously Reported
Mezzanine equity
Redeemable non-controlling interests, preferred shares, zero par value, 1,000,000 shares authorized, 3,138 shares issued and outstanding at June 30, 2022 and December 31, 2021; aggregate liquidation preference of $3,330,071 at June 30, 2022		3,208,360
Stockholders’ (Deficit) Equity
Additional paid-in capital		134,261,487
Accumulated deficit		(107,629,843)
Nuvve Holding Corp. Stockholders’ Equity (Deficit)		26,707,078
Non-controlling interests		(3,236,683)
Total Stockholders’ Equity (Deficit)		23,470,395		71,410,982				94,830,025
Adjustment
Mezzanine equity
Redeemable non-controlling interests, preferred shares, zero par value, 1,000,000 shares authorized, 3,138 shares issued and outstanding at June 30, 2022 and December 31, 2021; aggregate liquidation preference of $3,330,071 at June 30, 2022		16,472
Stockholders’ (Deficit) Equity
Additional paid-in capital		(4,801,897)
Accumulated deficit		4,793,496
Nuvve Holding Corp. Stockholders’ Equity (Deficit)		(8,401)
Non-controlling interests		(8,071)
Total Stockholders’ Equity (Deficit)		$ (16,472)		$ (47,913,319)				$ (54,941,000)

[1]Note 2.[2]See Note 2.

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Restatement of Previously Issued Financial Statements - Condensed Consolidated Statements of Operations (Details) - USD ($)		3 Months Ended							6 Months Ended				12 Months Ended
		Jun. 30, 2022		Mar. 31, 2022		Jun. 30, 2021		Mar. 31, 2021	Jun. 30, 2022		Jun. 30, 2021		Dec. 31, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Financing costs	[1]	$ 0				$ (43,818,000)			$ 0		$ (43,818,000)
Change in fair value of warrants liability	[1]	4,585,000				(3,497,230)			9,361,000		(3,075,400)
Total other income (expense), net	[1]	4,581,429				(46,809,570)			9,382,572		(47,097,404)
Loss before taxes	[1]	(5,458,101)				(53,149,934)			(10,189,362)		(58,511,654)
Net loss		(5,458,101)	[1],[2]	$ (4,731,261)	[2]	(53,150,934)	[1]	$ (5,361,720)	(10,189,362)	[1]	(58,512,654)	[3]	$ 27,200,000	$ 4,700,000
Less: Net loss attributable to non-controlling interests	[1]	(189,945)				0			(290,878)		0
Net loss attributable to Nuvve Holding Corp.	[1]	(5,268,156)				(53,150,934)			(9,898,484)		(58,512,654)
Net loss attributable to Nuvve common stockholders	[1]	$ (5,494,918)				$ (53,150,934)			$ (10,350,727)		$ (58,512,654)
Net loss per share attributable to Nuvve common stockholders, basic (in Dollars per share)	[1]	$ (0.29)				$ (2.85)			$ (0.55)		$ (4.02)
Net loss per share attributable to Nuvve common stockholders, diluted (in Dollars per share)	[1]	$ (0.29)				$ (2.85)			$ (0.55)		$ (4.02)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Financing costs		$ (43,562,847)				$ 0			$ (43,562,847)		$ 0
Change in fair value of warrants liability		251,000				(351,602)			684,000		70,228
Total other income (expense), net		(43,315,418)				154,058			(42,857,275)		(133,776)
Loss before taxes		(53,354,948)				(6,186,306)			(62,429,209)		(11,548,026)
Net loss		(53,354,948)		(9,074,261)		(6,187,306)			(62,429,209)		(11,549,026)
Less: Net loss attributable to non-controlling interests		(2,110,903)				0			(2,211,837)		0
Net loss attributable to Nuvve Holding Corp.		(51,244,045)				(6,187,306)			(60,217,372)		(11,549,026)
Net loss attributable to Nuvve common stockholders		$ (51,470,807)				$ (6,187,306)			$ (60,669,615)		$ (11,549,026)
Net loss per share attributable to Nuvve common stockholders, basic (in Dollars per share)		$ (2.70)				$ (0.33)			$ (3.20)		$ (0.79)
Net loss per share attributable to Nuvve common stockholders, diluted (in Dollars per share)		$ (2.70)							$ (3.20)		$ (0.79)
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Financing costs		$ 43,562,847				$ (43,818,000)			$ 43,562,847		$ (43,818,000)
Change in fair value of warrants liability		4,334,000				(3,145,628)			8,677,000		(3,145,628)
Total other income (expense), net		47,896,847				(46,963,628)			52,239,847		(46,963,628)
Loss before taxes		47,896,847				(46,963,628)			52,239,847		(46,963,628)
Net loss		47,896,847		$ 4,343,000		(46,963,628)			52,239,847		(46,963,628)
Less: Net loss attributable to non-controlling interests		1,920,958				0			1,920,959		0
Net loss attributable to Nuvve Holding Corp.		45,975,889				(46,963,628)			50,318,888		(46,963,628)
Net loss attributable to Nuvve common stockholders		$ 45,975,889				$ (46,963,628)			$ 50,318,888		$ (46,963,628)
Net loss per share attributable to Nuvve common stockholders, basic (in Dollars per share)		$ 2.41				$ (2.52)			$ 2.65		$ (3.23)
Net loss per share attributable to Nuvve common stockholders, diluted (in Dollars per share)		$ 2.41							$ 2.65		$ (3.23)

[1]Note 2.[2]See Note 2.[3]Note 2.

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Restatement of Previously Issued Financial Statements - Condensed Consolidated Statements of Comprehensive Loss (Details) - USD ($)		3 Months Ended							6 Months Ended				12 Months Ended
		Jun. 30, 2022		Mar. 31, 2022		Jun. 30, 2021		Mar. 31, 2021	Jun. 30, 2022		Jun. 30, 2021		Dec. 31, 2021	Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss		$ (5,458,101)	[1],[2]	$ (4,731,261)	[2]	$ (53,150,934)	[1]	$ (5,361,720)	$ (10,189,362)	[1]	$ (58,512,654)	[3]	$ 27,200,000	$ 4,700,000
Less: Comprehensive loss attributable to non-controlling interests	[3]	(189,945)				0			(290,878)		0
Comprehensive loss attributable to Nuvve common stockholders	[3]	(5,067,708)				(53,171,080)			(9,486,239)		(58,416,051)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss		(53,354,948)		(9,074,261)		(6,187,306)			(62,429,209)		(11,549,026)
Less: Comprehensive loss attributable to non-controlling interests		(2,110,903)				0			(2,211,837)		0
Comprehensive loss attributable to Nuvve common stockholders		(51,043,497)				(6,207,452)			(59,805,127)		(11,452,423)
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net loss		47,896,847		$ 4,343,000		(46,963,628)			52,239,847		(46,963,628)
Less: Comprehensive loss attributable to non-controlling interests		1,920,958				0			1,920,959		0
Comprehensive loss attributable to Nuvve common stockholders		$ 45,975,789				$ (46,963,628)			$ 50,318,888		$ (46,963,628)

[1]Note 2.[2]See Note 2.[3]Note 2.

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Restatement of Previously Issued Financial Statements - Condensed Consolidated Statements of Stockholders' Equity (Details) - USD ($)	3 Months Ended							6 Months Ended				12 Months Ended
	Jun. 30, 2022		Mar. 31, 2022		Jun. 30, 2021		Mar. 31, 2021	Jun. 30, 2022		Jun. 30, 2021		Dec. 31, 2021		Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Issuance of warranties to Stonepeak and Evolve					$ 22,256,628
Net loss	$ (5,458,101)	[1],[2]	$ (4,731,261)	[2]	(53,150,934)	[1]	$ (5,361,720)	$ (10,189,362)	[1]	$ (58,512,654)	[3]	$ 27,200,000		$ 4,700,000
Balance, ending	23,453,923	[2],[4]	23,497,663	[2]	39,889,025		$ 57,394,610	23,453,923	[2],[4]	39,889,025		$ 27,012,445	[2],[4]	$ (880,710)
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Issuance of warranties to Stonepeak and Evolve					30,234,000
Net loss	(53,354,948)		(9,074,261)		(6,187,306)			(62,429,209)		(11,549,026)
Balance, ending	23,470,395		71,410,982		94,830,025			23,470,395		94,830,025
Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Issuance of warranties to Stonepeak and Evolve					(7,977,372)
Net loss	47,896,847		4,343,000		(46,963,628)			52,239,847		(46,963,628)
Balance, ending	$ (16,472)		$ (47,913,319)		$ (54,941,000)			$ (16,472)		$ (54,941,000)

[1]Note 2.[2]See Note 2.[3]Note 2.[4]Note 2.

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Restatement of Previously Issued Financial Statements - Condensed Consolidated Statements of Cash Flows (Details) - USD ($)		3 Months Ended							6 Months Ended				12 Months Ended
		Jun. 30, 2022		Mar. 31, 2022		Jun. 30, 2021		Mar. 31, 2021	Jun. 30, 2022		Jun. 30, 2021		Dec. 31, 2021	Dec. 31, 2020
Operating activities
Net loss		$ (5,458,101)	[1],[2]	$ (4,731,261)	[2]	$ (53,150,934)	[1]	$ (5,361,720)	$ (10,189,362)	[1]	$ (58,512,654)	[3]	$ 27,200,000	$ 4,700,000
Adjustments to reconcile to net loss to net cash used in operating activities
Financing costs									0		43,818,000
Change in fair value of warrants liability	[1]	(4,585,000)				3,497,230			(9,361,000)		3,075,400
Net cash used in operating activities									(20,021,165)		(13,413,426)
As Previously Reported
Operating activities
Net loss		(53,354,948)		(9,074,261)		(6,187,306)			(62,429,209)		(11,549,026)
Adjustments to reconcile to net loss to net cash used in operating activities
Financing costs									43,562,847		0
Change in fair value of warrants liability		(251,000)				351,602			(684,000)		(70,228)
Net cash used in operating activities									(20,021,165)		(13,413,426)
Adjustment
Operating activities
Net loss		47,896,847		$ 4,343,000		(46,963,628)			52,239,847		(46,963,628)
Adjustments to reconcile to net loss to net cash used in operating activities
Financing costs									(43,562,847)		43,818,000
Change in fair value of warrants liability		$ (4,334,000)				$ 3,145,628			(8,677,000)		3,145,628
Net cash used in operating activities									$ 0		$ 0

[1]Note 2.[2]See Note 2.[3]Note 2.

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Assets and liabilities of consolidated VIEs (Details) - USD ($)		Jun. 30, 2022	Dec. 31, 2021
Assets
Cash	[1]	$ 14,890,242	$ 32,360,520
Total Assets	[1]	39,629,515	52,914,543
Liabilities, Mezzanine Equity and Stockholders’ Equity
Accrued expenses	[1]	2,392,820	2,874,018
Derivative liability - non-controlling redeemable preferred shares	[1]	491,012	511,948
Total Liabilities	[1]	12,809,910	$ 23,000,199
Variable Interest Entity \| Levo Mobility LLC
Assets
Cash		28,068
Total Assets		28,068
Liabilities, Mezzanine Equity and Stockholders’ Equity
Accrued expenses		212,071
Derivative liability - non-controlling redeemable preferred shares		491,012
Total Liabilities		$ 703,083

[1]Note 2.

Summary of Significant Accou_11

Summary of Significant Accounting Policies - Concentrations of Credit Risk (Details) - Customer Concentration Risk	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Revenue Benchmark \| Customer 3
Revenue, Major Customer [Line Items]
Concentration risk	54.90%	56.40%	54.90%	56.40%
Revenue Benchmark \| Customer 2
Revenue, Major Customer [Line Items]
Concentration risk	58.80%	48.60%	58.80%	48.60%
Revenue Benchmark \| Top 5 Customers
Revenue, Major Customer [Line Items]
Concentration risk	71.80%	68.30%	70.10%	71%
Accounts Receivable \| Customer 2
Revenue, Major Customer [Line Items]
Concentration risk			37.10%		32.20%
Accounts Receivable \| Top 5 Customers
Revenue, Major Customer [Line Items]
Concentration risk			58.50%		56%

Revenue Recognition - Schedule

Revenue Recognition - Schedule of information regarding disaggregated revenue based on revenue by service (Details) - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Deferred Revenue Arrangement [Line Items]
Total revenue	[1]	$ 1,301,727	$ 981,330	$ 3,672,760	$ 1,780,362
Services
Deferred Revenue Arrangement [Line Items]
Total revenue		73,522	363,366	268,172	530,611
Grants
Deferred Revenue Arrangement [Line Items]
Total revenue	[1]	233,698	214,814	350,947	701,943
Products
Deferred Revenue Arrangement [Line Items]
Total revenue		$ 994,507	$ 403,150	$ 3,053,641	$ 547,808

[1]Note 2.

Revenue Recognition - Schedul_2

Revenue Recognition - Schedule of aggregate amount of revenue for the Company’s existing contracts with customers (Details)	Jun. 30, 2022 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 781,922
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 138,399
Revenue, remaining performance obligation, expected timing of satisfaction, period	6 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 643,523
Revenue, remaining performance obligation, expected timing of satisfaction, period

Revenue Recognition - Schedul_3

Revenue Recognition - Schedule of segment reporting (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Segment Reporting Information [Line Items]
Revenues	$ 1,301,727	$ 981,330	$ 3,672,760	$ 1,780,362
Long-lived assets	1,936,512		1,936,512		$ 1,837,271
United States
Segment Reporting Information [Line Items]
Revenues	1,125,586	812,796	3,353,976	1,404,627
Long-lived assets	1,915,685		1,915,685		1,811,607
United Kingdom
Segment Reporting Information [Line Items]
Revenues	99,995	113,703	137,385	254,989
Denmark
Segment Reporting Information [Line Items]
Revenues	76,146	$ 54,831	181,399	$ 120,746
Long-lived assets	$ 20,827		$ 20,827		$ 25,664

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of liabilities measured at fair value on the condensed consolidated balance sheet (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Recurring fair value measurements
Total recurring fair value measurements	$ 673,012	$ 12,306,000	$ 673,012	$ 12,306,000
Recurring fair value measurements, gain (loss) during period	4,552,464	(3,497,230)	9,381,936	(3,075,400)
Derivative liability - non-controlling redeemable preferred shares
Recurring fair value measurements
Total recurring fair value measurements	491,012		491,012
Recurring fair value measurements, gain (loss) during period	(32,536)		20,936
Private Warrants
Recurring fair value measurements
Total recurring fair value measurements	182,000	1,183,000	182,000	1,183,000
Recurring fair value measurements, gain (loss) during period	251,000	(351,602)	684,000	70,228
Stonepeak Warrants
Recurring fair value measurements
Total recurring fair value measurements	0	11,123,000	0	11,123,000
Recurring fair value measurements, gain (loss) during period	4,334,000	(3,145,628)	8,677,000	(3,145,628)
Level 1: Quoted Prices in Active Markets for Identical Assets
Recurring fair value measurements
Total recurring fair value measurements	0	0	0	0
Level 1: Quoted Prices in Active Markets for Identical Assets \| Derivative liability - non-controlling redeemable preferred shares
Recurring fair value measurements
Total recurring fair value measurements	0		0
Level 1: Quoted Prices in Active Markets for Identical Assets \| Private Warrants
Recurring fair value measurements
Total recurring fair value measurements	0	0	0	0
Level 1: Quoted Prices in Active Markets for Identical Assets \| Stonepeak Warrants
Recurring fair value measurements
Total recurring fair value measurements	0	0	0	0
Level 2: Significant Other Observable Inputs
Recurring fair value measurements
Total recurring fair value measurements	0	0	0	0
Level 2: Significant Other Observable Inputs \| Derivative liability - non-controlling redeemable preferred shares
Recurring fair value measurements
Total recurring fair value measurements	0		0
Level 2: Significant Other Observable Inputs \| Private Warrants
Recurring fair value measurements
Total recurring fair value measurements	0	0	0	0
Level 2: Significant Other Observable Inputs \| Stonepeak Warrants
Recurring fair value measurements
Total recurring fair value measurements	0	0	0	0
Level 3: Significant Unobservable Inputs
Recurring fair value measurements
Total recurring fair value measurements	673,012	12,306,000	673,012	12,306,000
Level 3: Significant Unobservable Inputs \| Derivative liability - non-controlling redeemable preferred shares
Recurring fair value measurements
Total recurring fair value measurements	491,012		491,012
Level 3: Significant Unobservable Inputs \| Private Warrants
Recurring fair value measurements
Total recurring fair value measurements	182,000	1,183,000	182,000	1,183,000
Level 3: Significant Unobservable Inputs \| Stonepeak Warrants
Recurring fair value measurements
Total recurring fair value measurements	$ 0	$ 11,123,000	$ 0	$ 11,123,000

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of fair value on a recurring basis (Details) - USD ($)	3 Months Ended
	Jun. 30, 2022	Mar. 31, 2022
Derivative liability - non-controlling redeemable preferred shares
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance	$ 458,476	$ 511,948
Total (gains) losses for period included in earnings	32,536	(53,472)
Balance	491,012	458,476
Private Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance	433,000	866,000
Total (gains) losses for period included in earnings	(251,000)	(433,000)
Balance	182,000	433,000
Stonepeak Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance	4,334,000	8,677,000
Total (gains) losses for period included in earnings	(4,334,000)	(4,343,000)
Balance	$ 0	$ 4,334,000

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details)	Jun. 30, 2022 $ / shares	Jun. 30, 2021 $ / shares	May 17, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, term			10 years
Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price (in Dollars per share)	$ 11.50
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivatives, term	2 years 1 month 2 days
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivatives, term	7 years
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Measurement Input, Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.030
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Measurement Input, Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.570
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Probability Of Redemption Trigger
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability, measurement input	0.750
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, term	3 years 8 months 19 days	4 years 8 months 19 days
Exercise price (in Dollars per share)	$ 11.50	$ 11.50
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Private Warrants \| Measurement Input, Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.030	0.0080
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Private Warrants \| Measurement Input, Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.670	0.880

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Techniques (Details)	Jun. 30, 2022 USD ($) $ / shares	Jun. 30, 2021 USD ($) $ / shares	May 17, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	$ 673,012	$ 12,306,000
Warrants outstanding, term			10 years
Series C Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price (in Dollars per share) \| $ / shares	$ 15
Series D Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price (in Dollars per share) \| $ / shares	20
Series E Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price (in Dollars per share) \| $ / shares	30
Series F Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Exercise price (in Dollars per share) \| $ / shares	$ 40
Level 3: Significant Unobservable Inputs
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	$ 673,012	12,306,000
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series C Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	$ 0	$ 3,800,000
Warrants outstanding, term	8 years 10 months 24 days	9 years 10 months 24 days
Exercise price (in Dollars per share) \| $ / shares	$ 15	$ 15
Capital expenditure forecast (in millions)	$ 125,000,000	$ 125,000,000
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series C Unvested Warrants \| Measurement Input, Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.030	0.014
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series C Unvested Warrants \| Measurement Input, Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.560	0.550
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series C Unvested Warrants \| Measurement Input, Probability of Warrants Vesting
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0	0.971
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series D Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	$ 0	$ 3,100,000
Warrants outstanding, term	8 years 10 months 24 days	9 years 10 months 24 days
Exercise price (in Dollars per share) \| $ / shares	$ 20	$ 20
Capital expenditure forecast (in millions)	$ 250,000,000	$ 250,000,000
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series D Unvested Warrants \| Measurement Input, Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.030	0.014
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series D Unvested Warrants \| Measurement Input, Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.560	0.550
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series D Unvested Warrants \| Measurement Input, Probability of Warrants Vesting
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0	0.882
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series E Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	$ 0	$ 2,400,000
Warrants outstanding, term	8 years 10 months 24 days	9 years 10 months 24 days
Exercise price (in Dollars per share) \| $ / shares	$ 30	$ 30
Capital expenditure forecast (in millions)	$ 375,000,000	$ 375,000,000
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series E Unvested Warrants \| Measurement Input, Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.030	0.014
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series E Unvested Warrants \| Measurement Input, Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.560	0.550
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series E Unvested Warrants \| Measurement Input, Probability of Warrants Vesting
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0	0.788
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series F Unvested Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value (in millions)	$ 0	$ 1,900,000
Warrants outstanding, term	8 years 10 months 24 days	9 years 10 months 24 days
Exercise price (in Dollars per share) \| $ / shares	$ 40	$ 40
Capital expenditure forecast (in millions)	$ 500,000,000	$ 500,000,000
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series F Unvested Warrants \| Measurement Input, Risk Free Interest Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.030	0.014
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series F Unvested Warrants \| Measurement Input, Price Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0.560	0.550
Level 3: Significant Unobservable Inputs \| Fair Value, Nonrecurring \| Series F Unvested Warrants \| Measurement Input, Probability of Warrants Vesting
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants and right outstanding, measurement input	0	0.704

Derivative Liability - Non-Co_3

Derivative Liability - Non-Controlling Redeemable Preferred Stock (Details) - USD ($)		Jun. 30, 2022	Dec. 31, 2021
Embedded Derivative [Line Items]
Derivative liability - non-controlling redeemable preferred shares	[1]	$ 491,012	$ 511,948
Other Long-term Liabilities
Embedded Derivative [Line Items]
Derivative liability - non-controlling redeemable preferred shares		$ 491,012	$ 511,948

[1]Note 2.

Investments (Details)

Investments (Details) - USD ($)	3 Months Ended		6 Months Ended
Investments (Details) - USD ($)	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 06, 2022
Investment Holdings [Line Items]
Company's equity ownership	13%		13%
Consulting services (in Dollars)	$ 0	$ 0	$ 0	$ 0
Switch EV
Investment Holdings [Line Items]
Company's equity ownership					5%
Equity method investments					$ 1,000,000

Account Receivables, Net (Detai

Account Receivables, Net (Details) - USD ($)		6 Months Ended
Account Receivables, Net (Details) - USD ($)		Jun. 30, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Less: allowance for doubtful accounts		$ (63,188)	$ (63,188)
Accounts receivable	[1]	1,958,656	1,886,708
Allowance for doubtful accounts:
Balance December 31, 2021		(63,188)
Provision		0
Write-off		0
Recoveries		0
Balance June 30, 2022		(63,188)
Trade Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Trade receivables		$ 2,021,844	$ 1,949,896

[1]Note 2.

Inventories (Details)

Inventories (Details)	6 Months Ended
Inventories (Details)	Jun. 30, 2022 USD ($) bus	Mar. 31, 2022 bus	Dec. 31, 2021 USD ($)
Inventory [Line Items]
Inventory, gross	$ 10,796,032		$ 11,118,188
Number of school buses delivered to company \| bus	10
Number of years for buses to be delivered	1 year
Number of school buses were sold \| bus		5
DC Chargers
Inventory [Line Items]
Inventory, gross	$ 8,852,624		7,687,598
AC Chargers
Inventory [Line Items]
Inventory, gross	214,486		232,920
Vehicles - School Buses
Inventory [Line Items]
Inventory, gross	1,620,000		3,180,000
Others
Inventory [Line Items]
Inventory, gross	$ 108,922		$ 17,670

Property, Plant and Equipment_2

Property, Plant and Equipment (Details) - USD ($)		6 Months Ended
Property, Plant and Equipment (Details) - USD ($)		Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross		$ 759,407		$ 442,182
Less: Accumulated Depreciation		(158,861)		(85,988)
Property and equipment, net	[1]	600,546		356,194
Depreciation expense		62,265	$ 12,147
Computers & Servers
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross		126,931		105,499
Vehicles
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross		168,862		168,862
Office furniture and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross		332,007		161,771
Others
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross		$ 131,607		$ 6,050

[1]Note 2.

Intangible Assets (Details)

Intangible Assets (Details) - USD ($)	3 Months Ended		6 Months Ended
Intangible Assets (Details) - USD ($)	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Gross intangible asset	$ 2,091,556		$ 2,091,556		$ 2,091,556
Amortization expense of intangible assets	34,860	$ 34,860	69,720	$ 69,720
Finite-lived intangible assets, accumulated amortization	680,200		680,200		$ 610,480
Finite-lived intangible assets, net	$ 1,411,358		$ 1,411,358
Acquire finite-lived intangible assets, weighted average useful life			10 years 4 months 24 days

Intangible Assets - Schedule of

Intangible Assets - Schedule of estimated future amortization expense amortizable intangible assets (Details)	Jun. 30, 2022 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2022 (remaining six months)	$ 69,719
2023	139,437
2024	139,437
2025	139,437
2026	139,437
Thereafter	783,891
Total estimated future amortization expense	$ 1,411,358

Stockholders_ Equity (Details)

Stockholders’ Equity (Details)							3 Months Ended		6 Months Ended
Stockholders’ Equity (Details)		May 05, 2022 USD ($)	Apr. 25, 2022 USD ($)	Nov. 11, 2020 USD ($) $ / shares shares	Nov. 11, 2020 $ / shares shares	Feb. 19, 2020 USD ($) $ / shares shares	Jun. 30, 2022 USD ($) class_of_stock $ / shares shares	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) class_of_stock $ / shares shares	Jun. 30, 2021 USD ($)	Dec. 31, 2021 $ / shares shares	May 17, 2021 USD ($) $ / shares shares
Stockholders' Equity [Line Items]
Number of classes of stock \| class_of_stock							2		2
Authorized capital stock (in Shares) \| shares									101,000,000
Common stock, shares authorized (in Shares) \| shares							100,000,000		100,000,000		100,000,000
Common stock par value (in Dollars per share) \| $ / shares							$ 0.0001		$ 0.0001		$ 0.0001
Preferred stock, shares authorized (in Shares) \| shares							1,000,000		1,000,000
Preferred stock par value (in Dollars per share) \| $ / shares							$ 0.0001		$ 0.0001
Agent fee percentage									6%
Sale price (in Dollars per share) \| $ / shares												$ 50
Proceeds from common stock offering, net of offering costs									$ 1,859,685	$ 0
Warrants outstanding, term												10 years
Financing costs	[1]						$ 0	$ 43,818,000	0	43,818,000
Total recurring fair value measurements							673,012	12,306,000	673,012	12,306,000
Recurring fair value measurements, gain (loss) during period							$ 4,552,464	(3,497,230)	$ 9,381,936	(3,075,400)
Purchase agreement, authorized amount												$ 250,000,000
Grant date fair value of securities purchase agreement												$ 12,600,000
Stonepeak
Stockholders' Equity [Line Items]
Percent of warrants issued												90%
Evolve
Stockholders' Equity [Line Items]
Percent of warrants issued												10%
Unit Purchase Option
Stockholders' Equity [Line Items]
Number of shares included in a unit						1.1
Shares issued (in Dollars per share) \| $ / shares						$ 100
Exercisable units (in shares) \| shares						316,250
Options exercisable (in Dollars per share) \| $ / shares						$ 11.50
Aggregate exercise price						$ 3,636,875
Unit Purchase Option \| Minimum
Stockholders' Equity [Line Items]
Right to registration, period						5 years
Unit Purchase Option \| Maximum
Stockholders' Equity [Line Items]
Right to registration, period						7 years
Investor
Stockholders' Equity [Line Items]
Common stock shares purchase (in Shares) \| shares				1,425,000
Purchase price per share value (in Dollars per share) \| $ / shares				$ 10	$ 10
PIPE
Stockholders' Equity [Line Items]
Sale of units (in Shares) \| shares					1.9
Sale price (in Dollars per share) \| $ / shares				$ 11.50	$ 11.50
Aggregate purchase price of common stock (in Dollars)				$ 14,250,000
Stonepeak/Evolve Warrants - series B
Stockholders' Equity [Line Items]
Warrants outstanding, grant date fair value												$ 12,800,000
Exercise price (in Dollars per share) \| $ / shares							$ 10		$ 10
Stonepeak/Evolve Warrants - series C
Stockholders' Equity [Line Items]
Warrants outstanding, grant date fair value												5,600,000
Exercise price (in Dollars per share) \| $ / shares							15		15
Stonepeak/Evolve Warrants - series D
Stockholders' Equity [Line Items]
Warrants outstanding, grant date fair value												4,800,000
Exercise price (in Dollars per share) \| $ / shares							20		20
Stonepeak/Evolve Warrants - series E
Stockholders' Equity [Line Items]
Warrants outstanding, grant date fair value												3,800,000
Exercise price (in Dollars per share) \| $ / shares							30		30
Stonepeak/Evolve Warrants - series F
Stockholders' Equity [Line Items]
Warrants outstanding, grant date fair value												$ 3,200,000
Exercise price (in Dollars per share) \| $ / shares							40		$ 40
Warrants
Stockholders' Equity [Line Items]
Sale of units (in Shares) \| shares						5,750,000
Stonepeak Warrants \| Securities Purchase Agreement
Stockholders' Equity [Line Items]
Percent of warrants issued												90%
Evolve Warrants \| Securities Purchase Agreement
Stockholders' Equity [Line Items]
Percent of warrants issued												10%
Stonepeak/Evolve Warrants - series B
Stockholders' Equity [Line Items]
Number of securities called by warrants (in shares) \| shares												2,000,000
Exercise price (in Dollars per share) \| $ / shares												$ 10
Stonepeak/Evolve Warrants - series C
Stockholders' Equity [Line Items]
Number of securities called by warrants (in shares) \| shares												1,000,000
Percent of warrants vested upon issuance												50%
Additional capital expenditure to trigger exercise of nonvested warrants												$ 125,000,000
Percent of warrants vested upon additional capital expenditures												50%
Exercise price (in Dollars per share) \| $ / shares												$ 15
Stonepeak/Evolve Warrants - series D
Stockholders' Equity [Line Items]
Number of securities called by warrants (in shares) \| shares												1,000,000
Percent of warrants vested upon issuance												50%
Additional capital expenditure to trigger exercise of nonvested warrants												$ 250,000,000
Percent of warrants vested upon additional capital expenditures												50%
Exercise price (in Dollars per share) \| $ / shares												$ 20
Stonepeak/Evolve Warrants - series E
Stockholders' Equity [Line Items]
Number of securities called by warrants (in shares) \| shares												1,000,000
Percent of warrants vested upon issuance												50%
Additional capital expenditure to trigger exercise of nonvested warrants												$ 375,000,000
Percent of warrants vested upon additional capital expenditures												50%
Exercise price (in Dollars per share) \| $ / shares												$ 30
Stonepeak/Evolve Warrants - series F
Stockholders' Equity [Line Items]
Number of securities called by warrants (in shares) \| shares												1,000,000
Percent of warrants vested upon issuance												50%
Additional capital expenditure to trigger exercise of nonvested warrants												$ 500,000,000
Percent of warrants vested upon additional capital expenditures												50%
Exercise price (in Dollars per share) \| $ / shares												$ 40
Shelf Registration
Stockholders' Equity [Line Items]
Gross proceeds from offering			$ 100,000,000
At The Market Offering
Stockholders' Equity [Line Items]
Gross proceeds from offering		$ 25,000,000
Agent fee percentage		3%
Sale of units (in Shares) \| shares									323,746
Sale price (in Dollars per share) \| $ / shares							$ 6.12		$ 6.12
Proceeds from common stock offering, net of offering costs									$ 1,900,000
IPO \| Newborn
Stockholders' Equity [Line Items]
Number of warrants per unit (in Shares) \| shares						1
Percent of one share of common stock						50%
Class of warrant or right, number of securities called by each warrant \| shares						1
Private Placement \| Newborn
Stockholders' Equity [Line Items]
Number of warrants per unit (in Shares) \| shares						1
Private Placement \| Warrants
Stockholders' Equity [Line Items]
Aggregate share purchase (in Shares) \| shares						272,500
Private Warrants
Stockholders' Equity [Line Items]
Total recurring fair value measurements							$ 182,000	1,183,000	182,000	1,183,000
Recurring fair value measurements, gain (loss) during period							$ 251,000	$ (351,602)	$ 684,000	$ 70,228

[1]Note 2.

Stockholders_ Equity - Schedule

Stockholders’ Equity - Schedule of common stock issuable upon exercise of warrants outstanding (Details)	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	10,365,000
Number of Warrants Exercisable (in shares)	8,365,000
Public Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	2,875,000
Number of Warrants Exercisable (in shares)	2,875,000
Exercise price (in Dollars per share) \| $ / shares	$ 11.50
Private Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	136,250
Number of Warrants Exercisable (in shares)	136,250
Exercise price (in Dollars per share) \| $ / shares	$ 11.50
PIPE Warrants
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	1,353,750
Number of Warrants Exercisable (in shares)	1,353,750
Exercise price (in Dollars per share) \| $ / shares	$ 11.50
Stonepeak/Evolve Warrants - series B
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	2,000,000
Number of Warrants Exercisable (in shares)	2,000,000
Exercise price (in Dollars per share) \| $ / shares	$ 10
Stonepeak/Evolve Warrants - series C
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	1,000,000
Number of Warrants Exercisable (in shares)	500,000
Exercise price (in Dollars per share) \| $ / shares	$ 15
Stonepeak/Evolve Warrants - series D
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	1,000,000
Number of Warrants Exercisable (in shares)	500,000
Exercise price (in Dollars per share) \| $ / shares	$ 20
Stonepeak/Evolve Warrants - series E
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	1,000,000
Number of Warrants Exercisable (in shares)	500,000
Exercise price (in Dollars per share) \| $ / shares	$ 30
Stonepeak/Evolve Warrants - series F
Stockholders’ Equity (Details) - Schedule of common stock issuable upon exercise of warrants outstanding [Line Items]
Number of Warrants (in shares)	1,000,000
Number of Warrants Exercisable (in shares)	500,000
Exercise price (in Dollars per share) \| $ / shares	$ 40

Stock Option Plan - Narrative (

Stock Option Plan - Narrative (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
Stock Option Plan - Narrative (Details) - USD ($)	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based option modified (in Shares)					1,640,000
Increase decrease exercise price (in Dollars per share)					$ 0.60
Incremental compensation cost (in Dollars)					$ 246,000
Unrecognized compensation costs, period of recognition			2 years 9 months 18 days
Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional compensation expense	$ 25,459	$ 21,728	$ 45,158	$ 21,728
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost related to nonvested restricted stock	$ 1,668,498		$ 1,668,498
Unrecognized compensation costs, period of recognition			1 year 10 months 24 days
2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate of common shares (in Shares)	3,300,000		3,300,000
Option contractual life			10 years
Issuance of common stock available for future (in Shares)	1,262,865		1,262,865
Weighted average grant date fair value of options granted during period (in Dollars per share)			$ 3.55
2020 Plan \| Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option vesting period			4 years
2010 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value of options granted during period (in Dollars per share)			$ 0

Stock Option Plan - Schedule of

Stock Option Plan - Schedule of stock-based compensation expense for stock options (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Options
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	$ 548,652	$ 810,738	$ 1,370,758	$ 1,063,008
Restricted stock
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	1,187,254	258,137	1,801,093	267,972
Options and Restricted Stock
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation	$ 1,735,906	$ 1,068,875	$ 3,171,851	$ 1,330,980

Stock Option Plan - Schedule _2

Stock Option Plan - Schedule of black-scholes option pricing model to estimate the fair value of stock options (Details)	6 Months Ended
	Jun. 30, 2022
2010 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life of options (in years)	6 years 1 month 6 days
Dividend yield	0%
Risk-free interest rate	2%
Volatility	54.10%
2020 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life of options (in years)	6 years 1 month 6 days
Dividend yield	0%
Risk-free interest rate	2%
Volatility	54.10%

Stock Option Plan - Schedule _3

Stock Option Plan - Schedule of stock option activity (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
2010 Plan
Shares
Beginning balance (in Shares) \| shares	1,035,035
Granted, (in Shares) \| shares	0
Exercised (in Shares) \| shares	(42,729)
Forfeited (in Shares) \| shares	(36,065)
Expired/Cancelled (in Shares) \| shares	(5,310)
Ending balance (in Shares) \| shares	950,931	1,035,035
Options exercisable (in Shares) \| shares	836,687
Options vested (in Shares) \| shares	836,687
Weighted- Average Exercise Price per Share($)
Beginning balance (in Dollars per share) \| $ / shares	$ 3.21
Granted (in Dollars per share) \| $ / shares	0
Exercised (in Dollars per share) \| $ / shares	2.42
Forfeited (in Dollars per share) \| $ / shares	7.61
Expired/Cancelled (in Dollars per share) \| $ / shares	1.37
Ending balance (in Dollars per share) \| $ / shares	3.09	$ 3.21
Options exercisable (in Dollars per share) \| $ / shares	2.52
Options vested (in Dollars per share) \| $ / shares	$ 2.52
Weighted- Average Remaining Contractual Term (Years)
Outstanding, weighted-average remaining contractual term	5 years 2 months 26 days	5 years 10 months 24 days
Options exercisable, weighted average remaining contractual term	4 years 10 months 2 days
Options vested, weighted average remaining contractual term	4 years 10 months 2 days
Aggregate Intrinsic Value($)
Outstanding \| $	$ 2,264,735	$ 5,688,201
Exercisable \| $	2,257,456
Vested \| $	$ 2,257,456
2020 Plan
Shares
Beginning balance (in Shares) \| shares	1,602,850
Granted, (in Shares) \| shares	121,100
Exercised (in Shares) \| shares	0
Forfeited (in Shares) \| shares	(128,450)
Expired/Cancelled (in Shares) \| shares	(1,250)
Ending balance (in Shares) \| shares	1,594,250	1,602,850
Options exercisable (in Shares) \| shares	422,327
Options vested (in Shares) \| shares	422,327
Weighted- Average Exercise Price per Share($)
Beginning balance (in Dollars per share) \| $ / shares	$ 13.18
Granted (in Dollars per share) \| $ / shares	6.87
Exercised (in Dollars per share) \| $ / shares	0
Forfeited (in Dollars per share) \| $ / shares	10.18
Expired/Cancelled (in Dollars per share) \| $ / shares	8.25
Ending balance (in Dollars per share) \| $ / shares	12.84	$ 13.18
Options exercisable (in Dollars per share) \| $ / shares	13.38
Options vested (in Dollars per share) \| $ / shares	$ 13.38
Weighted- Average Remaining Contractual Term (Years)
Outstanding, weighted-average remaining contractual term	8 years 9 months 29 days	9 years 3 months 7 days
Granted, weighted average remaining contractual term	9 years 10 months 9 days
Options exercisable, weighted average remaining contractual term	8 years 8 months 26 days
Options vested, weighted average remaining contractual term	8 years 8 months 26 days
Aggregate Intrinsic Value($)
Outstanding \| $	$ 0	$ 46,920
Exercisable \| $	0
Vested \| $	$ 0

Stock Option Plan - Schedule _4

Stock Option Plan - Schedule of other share based compensation information (Details) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Share-Based Payment Arrangement [Abstract]
Amount received from option exercised	$ 173,575	$ 0
Total unrecognized options compensation costs	$ 7,767,742
Unrecognized compensation costs, period of recognition	2 years 9 months 18 days

Stock Option Plan - Schedule _5

Stock Option Plan - Schedule of nonvested restricted stock units (Details) - Restricted Stock Units (RSUs)	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance (in Shares) \| shares	353,817
Granted (in Shares) \| shares	134,575
Vested/Release (in Shares) \| shares	(202,141)
Cancelled/Forfeited (in Shares) \| shares	(6,294)
Ending balance (in Shares) \| shares	279,957
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Beginning balance (in Dollars per share) \| $ / shares	$ 11
Granted (in Dollars per share) \| $ / shares	6.16
Vested/Release (in Dollars per share) \| $ / shares	11.15
Cancelled/Forfeited (in Dollars per share) \| $ / shares	9.93
Ending balance (in Dollars per share) \| $ / shares	$ 8.60

Income Taxes (Details)

Income Taxes (Details) - USD ($)		3 Months Ended		6 Months Ended
Income Taxes (Details) - USD ($)		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Tax Disclosure [Abstract]
Income tax (benefit) expense	[1]	$ 0	$ 1,000	$ 0	$ 1,000
Effective tax rate		0%	0%	0%	0%

[1]Note 2.

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Schedule of Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($)		3 Months Ended		6 Months Ended
		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Earnings Per Share [Abstract]
Net loss attributable to Nuvve common stockholders	[1]	$ (5,494,918)	$ (53,150,934)	$ (10,350,727)	$ (58,512,654)
Net loss attributable to Nuvve common stockholders, diluted		$ (5,494,918)	$ (53,150,934)	$ (10,350,727)	$ (58,512,654)
Weighted-average shares used in computing net loss per share attributable to Nuvve Holding Corp. common stockholders, basic (in Shares)	[1]	19,064,854	18,668,009	18,965,167	14,560,862
Weighted-average shares used in computing net loss per share attributable to Nuvve Holding Corp. common stockholders, diluted (in Shares)	[1]	19,064,854	18,668,009	18,965,167	14,560,862
Net loss per share attributable to Nuvve common stockholders, basic (in Dollars per share)	[1]	$ (0.29)	$ (2.85)	$ (0.55)	$ (4.02)
Net loss per share attributable to Nuvve common stockholders, diluted (in Dollars per share)	[1]	$ (0.29)	$ (2.85)	$ (0.55)	$ (4.02)

[1]Note 2.

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Schedule of Diluted Net Loss Attributable to Nuvve common stockholders (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	18,923,118	12,866,935	19,091,549	7,504,346
Stock options issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	2,688,173	2,505,711	2,858,756	1,792,556
Nonvested restricted stock issued and outstanding
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	869,945	677,543	867,793	582,148
Public warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	2,875,000	2,875,000	2,875,000	1,627,060
Private warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	136,250	136,250	136,250	77,109
PIPE warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	1,353,750	1,353,750	1,353,750	766,133
Stonepeak and Evolve warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	6,000,000	2,901,099	6,000,000	1,450,549
Stonepeak and Evolve options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from the computation of earnings per share (in Shares)	5,000,000	2,417,582	5,000,000	1,208,791

Related Parties (Details)

Related Parties (Details) - USD ($)			3 Months Ended		6 Months Ended
Related Parties (Details) - USD ($)	Jun. 30, 2022	Apr. 23, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	May 17, 2021
Related Party Transaction [Line Items]
Revenue from related parties			$ 0	$ 252,000	$ 28,000	$ 399,620
Accounts receivable, related parties	$ 0		$ 0		$ 0
Sale price (in Dollars per share)							$ 50
Chief Executive Officer And Chief Operating Officer
Related Party Transaction [Line Items]
Sale of units (in Shares)	134,499	134,499
Sale price (in Dollars per share)	$ 14.87	$ 14.87	$ 14.87		$ 14.87
Gross proceeds from offering	$ 2,000,000	$ 2,000,000

Leases - Narrative (Details)

Leases - Narrative (Details) - ft²	Apr. 15, 2022	Nov. 03, 2021
Lessee, Lease, Description [Line Items]
Operating lease, rental abatement period	2 months
Main Office Lease
Lessee, Lease, Description [Line Items]
Net rentable area		4,811
Operating lease, fixed percent increase in rental payment		3%

Leases - Lease cost (Details)

Leases - Lease cost (Details) - USD ($)		3 Months Ended		6 Months Ended
Leases - Lease cost (Details) - USD ($)		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Lessee, Lease, Description [Line Items]
Right-of-use operating assets	[1]	$ 5,195,474		$ 5,195,474		$ 3,483,042
Finance lease assets		20,827		20,827
Operating and finance lease right-of-use assets		$ 5,216,301		$ 5,216,301
Finance lease, right-of-use asset, statement of financial position [extensible list]		Property and equipment, net		Property and equipment, net
Operating lease liabilities - current	[1]	$ 455,064		$ 455,064		41,513
Operating lease liabilities - noncurrent	[1]	5,053,219		5,053,219		$ 3,441,642
Finance lease liabilities - current		7,022		7,022
Finance lease liabilities - noncurrent		15,120		15,120
Total lease obligations		$ 5,530,425		$ 5,530,425
Operating lease, liability, noncurrent, statement of financial position, extensible list		Operating lease liabilities - noncurrent		Operating lease liabilities - noncurrent
Finance lease, liability, current, statement of financial position, extensible list		Other liabilities		Other liabilities
Finance lease, liability, noncurrent, statement of financial position, extensible list		Other long-term liabilities		Other long-term liabilities
Total lease expense		$ 166,126	$ 36,096	$ 349,226	$ 94,527
Selling, general and administrative
Lessee, Lease, Description [Line Items]
Operating lease expense		164,076	33,396	340,597	91,827
Amortization of finance lease assets		1,451	2,190	7,391	2,190
Interest expense
Lessee, Lease, Description [Line Items]
Interest expense		$ 599	$ 510	$ 1,238	$ 510

[1]Note 2.

Leases - Schedule of operating

Leases - Schedule of operating lease liability maturity (Details)	Jun. 30, 2022 USD ($)
Operating Lease
2022	$ 127,621
2023	792,918
2024	824,712
2025	822,352
2026	847,022
Thereafter	4,631,866
Total lease payments	8,046,491
Less: interest	(2,538,208)
Total lease obligations	5,508,283
Finance Lease
2022	3,511
2023	7,022
2024	7,022
2025	7,022
2026	0
Thereafter	1,755
Total lease payments	26,332
Less: interest	(4,190)
Total lease obligations	$ 22,142

Leases - Lease term, discount r

Leases - Lease term, discount rate, and other information (Details) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Weighted-average remaining lease terms (in years):
Operating lease	9 years 6 months
Finance lease	3 years 9 months 18 days
Weighted-average discount rate:
Operating lease	7.80%
Finance lease	7.80%
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 80,869	$ 94,818
Operating cash flows from finance leases	1,238	510
Financing cash flows from finance leases	4,425	1,989
Leased assets obtained in exchange for new finance lease liabilities	20,827	29,977
Leased assets obtained in exchange for new operating lease liabilities	$ 0	$ 0

Leases - Sublease (Details)

Leases - Sublease (Details)	1 Months Ended	3 Months Ended		6 Months Ended
Leases - Sublease (Details)	Apr. 30, 2022 USD ($) ft²	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)
Lessee, Lease, Description [Line Items]
Net area subleased \| ft²	4,811
Sublease monthly rental income	$ 2,250
Minimum
Lessee, Lease, Description [Line Items]
Sublease term	6 months
Maximum
Lessee, Lease, Description [Line Items]
Sublease term	12 months
Other, net
Lessee, Lease, Description [Line Items]
Sublease lease income		$ 20,125	$ 0	$ 20,125	$ 0

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($)		1 Months Ended	6 Months Ended	12 Months Ended
	Nov. 17, 2017	Oct. 31, 2021	Jun. 30, 2022	Dec. 31, 2021	Jul. 20, 2021	Jun. 30, 2021	Sep. 01, 2016
Other Commitments [Line Items]
Installment amount			$ 200,000			$ 200,000	$ 400,000
Research agreement, renewal period		1 year
Related party debt outstanding			$ 66,667
Property expire			20 years
Royalty expense, aggregate amount under agreement			$ 700,000
Royalty expense			0	$ 0
Acquisition costs, amortization period	15 years
Investment			270,000
Purchase obligation					$ 13,200,000
Purchase obligation, purchases			$ 5,300,000
IP Acquisition Agreement
Other Commitments [Line Items]
Asset acquisition, upfront payment	$ 500,000
Asset acquisition, equity consideration transferred	1,491,556
Asset acquisition, consideration transferred	1,991,556
Royalties payments	$ 7,500,000

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of milestone event (Details)	6 Months Ended
	Jun. 30, 2022 USD ($)
Other Commitments [Line Items]
Milestone payment amount	$ 7,500,000
10000
Other Commitments [Line Items]
Milestone payment amount	500,000
20000
Other Commitments [Line Items]
Milestone payment amount	750,000
40000
Other Commitments [Line Items]
Milestone payment amount	750,000
60000
Other Commitments [Line Items]
Milestone payment amount	750,000
80000
Other Commitments [Line Items]
Milestone payment amount	750,000
100000
Other Commitments [Line Items]
Milestone payment amount	1,000,000
200000
Other Commitments [Line Items]
Milestone payment amount	1,000,000
250000
Other Commitments [Line Items]
Milestone payment amount	$ 2,000,000

Non-Controlling Interest - Narr

Non-Controlling Interest - Narrative (Details)	6 Months Ended
Non-Controlling Interest - Narrative (Details)	Jun. 30, 2022 USD ($) vesting_installment $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Noncontrolling Interest [Line Items]
Temporary equity, shares authorized (in Shares) \| shares	1,000,000	1,000,000
Temporary equity, par value (in Dollars per share) \| $ / shares	$ 0	$ 0
Temporary equity, shares issued (in Shares) \| shares	3,138	3,138
Temporary equity, shares outstanding (in Shares) \| shares	3,138	3,138
Less: Non-controlling redeemable preferred shares - embedded derivatives	$ 497,606
Redeemable noncontrolling interest, equity, carrying amount	$ 2,640,394
Accretion period (in years)	7 years
Unrecognized compensation costs, period of recognition	2 years 9 months 18 days
Redeemable non controlling interests
Noncontrolling Interest [Line Items]
Redeemable noncontrolling interest, equity, carrying amount	$ 3,224,832	$ 2,901,899
Accretion value	$ 322,932
Class D Incentive Units
Noncontrolling Interest [Line Items]
Vesting percentage	80%
Number of vesting installments \| vesting_installment	4
Percentage of incentive units to be vested	20%
Compensation expense	$ 140,850
Total unrecognized compensation cost related to nonvested restricted stock	$ 2,698,822
Unrecognized compensation costs, period of recognition	3 years 9 months 18 days
Class D Incentive Units \| Share-Based Payment Arrangement, All Tranches
Noncontrolling Interest [Line Items]
Vesting percentage	80%
Class D Incentive Units \| Share-Based Payment Arrangement, Tranche One
Noncontrolling Interest [Line Items]
Vesting percentage	25%
Class D Incentive Units \| Share-Based Payment Arrangement, Tranche Two
Noncontrolling Interest [Line Items]
Vesting percentage	25%
Class D Incentive Units \| Share-Based Payment Arrangement, Tranche Three
Noncontrolling Interest [Line Items]
Vesting percentage	25%
Class D Incentive Units \| Share Based Arrangement Tranche Four
Noncontrolling Interest [Line Items]
Vesting percentage	25%
Levo Mobility LLC \| Series B Preferred Stock
Noncontrolling Interest [Line Items]
Temporary equity, shares authorized (in Shares) \| shares	1,000,000
Temporary equity, dividend rate, percentage	8%
Temporary equity, par value (in Dollars per share) \| $ / shares	$ 1,000
Temporary equity, accretion of dividends	$ 192,071
Temporary equity, shares issued (in Shares) \| shares	3,138
Temporary equity, shares outstanding (in Shares) \| shares	3,138
Redeemable noncontrolling interest, equity, fair value	$ 3,138,000

Non-Controlling Interest - Seri

Non-Controlling Interest - Series B Preferred Stock (Details) - USD ($)	6 Months Ended
	Jun. 30, 2022	Dec. 31, 2021
Noncontrolling Interest [Line Items]
Temporary equity, shares authorized (in Shares)	1,000,000	1,000,000
Temporary equity, shares outstanding (in Shares)	3,138	3,138
Temporary equity, shares issued (in Shares)	3,138	3,138
Temporary equity, par value (in Dollars per share)	$ 0	$ 0
Temporary equity, liquidation preference	$ 3,330,071
Series B Preferred Stock \| Levo Mobility LLC
Noncontrolling Interest [Line Items]
Temporary equity, shares authorized (in Shares)	1,000,000
Temporary equity, shares outstanding (in Shares)	3,138
Temporary equity, shares issued (in Shares)	3,138
Temporary equity, par value (in Dollars per share)	$ 1,000
Redeemable noncontrolling interest, equity, fair value	$ 3,138,000
Temporary equity, accretion of dividends	192,071
Temporary equity, liquidation preference	$ 3,330,071

Non-Controlling Interest - Non-

Non-Controlling Interest - Non-controlling interests presented as a separate component of stockholders’ equity (Details) - USD ($)		3 Months Ended			6 Months Ended
		Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Noncontrolling Interest [Line Items]
Add: Net loss attributable to non-controlling interests	[1]	$ (189,945)		$ 0	$ (290,878)	$ 0
Preferred dividends - non-controlling interest	[2]	65,296	$ 64,015
Non-controlling interests	[3]	(3,244,754)			(3,244,754)		$ (2,501,633)
Levo Mobility LLC
Noncontrolling Interest [Line Items]
Add: Net loss attributable to non-controlling interests					(290,878)
Preferred dividends - non-controlling interest					129,311
Preferred share Accretion adjustment as of June 30, 2022					322,932
Non-controlling interests		$ (743,121)			$ (743,121)

[1]Note 2.[2]See Note 2.[3]Note 2.

Non-Controlling Interest - Cond

Non-Controlling Interest - Condensed consolidated statements of operations (Details) - USD ($)	3 Months Ended	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2022
Levo Mobility LLC
Noncontrolling Interest [Line Items]
Net loss attributable to non-controlling interests	$ (189,945)	$ (290,878)

Non-Controlling Interest - Rede

Non-Controlling Interest - Redeemable noncontrolling interest reconciliation (Details)	6 Months Ended
	Jun. 30, 2022 USD ($)
Increase (Decrease) in Temporary Equity [Roll Forward]
Ending balance	$ 2,640,394
Redeemable non controlling interests
Increase (Decrease) in Temporary Equity [Roll Forward]
Beginning balance	2,901,899
Preferred share Accretion adjustment as of June 30, 2022	322,932
Ending balance	$ 3,224,832

Noncontrolling Interest - Sched

Noncontrolling Interest - Schedule of Monte Carlo Simulation model to estimate the fair value of class D incentive Units (Details) - Class D Incentive Units	6 Months Ended
	Jun. 30, 2022
Noncontrolling Interest [Line Items]
Expected life of options (in years)	5 years 6 months
Risk-free interest rate	3.02%
Volatility	69.50%

Noncontrolling Interest - Sch_2

Noncontrolling Interest - Schedule of nonvested Class D Incentive Units (Details) - Class D Incentive Units	6 Months Ended
	Jun. 30, 2022 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Beginning balance (in Shares) \| shares	0
Granted (in Shares) \| shares	250,000
Vested/Release (in Shares) \| shares	0
Cancelled/Forfeited (in Shares) \| shares	0
Ending balance (in Shares) \| shares	250,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Beginning balance (in Dollars per share) \| $ / shares	$ 0
Granted (in Dollars per share) \| $ / shares	13.28
Vested/Release (in Dollars per share) \| $ / shares	0
Cancelled/Forfeited (in Dollars per share) \| $ / shares	0
Ending balance (in Dollars per share) \| $ / shares	$ 13.28

Subsequent Events - Narrative (

Subsequent Events - Narrative (Details) - Subsequent Event - Warehouse Space	1 Months Ended
	Jul. 31, 2022 USD ($) ft²
Subsequent Event [Line Items]
Net rentable area \| ft²	10,000
Lease term (in years)	36 months
Operating lease expense \| $	$ 5,625
Operating lease, renewal term (in years)	36 months

Subsequent Events - New Lease L

Subsequent Events - New Lease Liability Maturity (Details)	Jun. 30, 2022 USD ($)
Operating Lease
2022	$ 127,621
2023	792,918
2024	824,712
2025	822,352
Total lease payments	8,046,491
Warehouse Space
Operating Lease
2022	39,375
2023	67,500
2024	67,500
2025	28,125
Total lease payments	$ 202,500

Subsequent Events - Securities

Subsequent Events - Securities Purchase Agreement, Pre-Funded Warrants and Warrants (Details) - USD ($) $ / shares in Units, $ in Millions			6 Months Ended
	Jul. 27, 2022	Feb. 19, 2020	Jun. 30, 2022	Dec. 31, 2021
Subsequent Event [Line Items]
Common stock par value (in Dollars per share)			$ 0.0001	$ 0.0001
Agent fee percentage			6%
Warrants
Subsequent Event [Line Items]
Sale of units (in Shares)		5,750,000
Subsequent Event
Subsequent Event [Line Items]
Per unit price (in Dollars per share)	$ 3.50
Gross proceeds from offering	$ 14
Net proceeds from offering	$ 13.1
Subsequent Event \| Common Stock
Subsequent Event [Line Items]
Sale of units (in Shares)	2,150,000
Common stock par value (in Dollars per share)	$ 0.0001
Subsequent Event \| Prefunded Warrant
Subsequent Event [Line Items]
Number of securities called by warrants (in shares)	1,850,000
Per unit price (in Dollars per share)	$ 3.4999
Exercise price (in Dollars per share)	$ 0.0001
Warrants or rights exercisable term	5 years
Subsequent Event \| Warrants
Subsequent Event [Line Items]
Number of securities called by warrants (in shares)	4,000,000
Exercise price (in Dollars per share)	$ 3.75
Class of warrant or right, number of securities called by each warrant	1